B_cell;CAF;Endo_cell;Macrophage;NK;Other_cells;T_cell;geo_accession;title;status;submission_date;last_update_date;type;channel_count;source_name_ch1;organism_ch1;characteristics_ch1;characteristics_ch1.1;characteristics_ch1.2;characteristics_ch1.3;characteristics_ch1.4;characteristics_ch1.5;characteristics_ch1.6;characteristics_ch1.7;treatment_protocol_ch1;growth_protocol_ch1;molecule_ch1;extract_protocol_ch1;label_ch1;label_protocol_ch1;taxid_ch1;hyb_protocol;scan_protocol;data_processing;platform_id;contact_name;contact_email;contact_institute;contact_address;contact_city;contact_state;contact_zip/postal_code;contact_country;supplementary_file;data_row_count;relation;number of primary melanomas:ch1;patient age at primary diagnosis (years):ch1;patient age at stage iii sample banked (years):ch1;patient last status:ch1;patient sex:ch1;stage at primary diagnosis 5th edition:ch1;survival from primary melanoma (months):ch1;survival from stage iii tumour banked (months):ch1
0,139045208;0;0,030185383;0,107264914;0,013927779;0,040857722;0,668718995;GSM1315904;melanoma AJCCstageIII TumourID217;Public on Aug 18 2014;Jan 28 2014;Aug 18 2014;RNA;1;melanoma lymph node, fresh frozen tissue (>80% tumor cell content, <30% necrosis);Homo sapiens;patient age at primary diagnosis (years): 19;patient sex: Female;patient age at stage iii sample banked (years): 22;survival from stage iii tumour banked (months): 110.37;survival from primary melanoma (months): 144.76;patient last status: Alive NSR;number of primary melanomas: 1;stage at primary diagnosis 5th edition: Stage II;Tissue samples were homogenized using a high-speed agitation polytron blender (Kinematica, Luzern, Switzerland) in the presence of Trizol.;Total RNA was extracted from 20-30mg of fresh frozen tissue.;total RNA;The RNA was isolated and purified with an RNeasy purification kit (Qiagen RNeasy purification kit- Qiagen Pty Ltd., Clifton Hill, Victoria, Australia) with DNAse I digestion on the column. The quality of the RNA preparations was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA, USA). RNA integrity scores were >8 for all samples analyzed.;biotin;cRNA amplification and labelling with biotin were performed using Illumina TotalPrep RNA amplification kit according to the manufacturer’s directions (Ambion, Inc., Austin, TX, USA) with 250ng total RNA as input material.;9606;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Quality control was performed on all chips using R/Bioconductor and the lumi package (www.bioconductor.org). Data normalization was performed using a variance-stabilizing transform (VST) and quantile normalization as implemented in the lumi package for R/Bioconductor. To reduce false positives, unexpressed genes (detection p-value >0.01) were removed, reducing the number of probes analysed from 48,802 to 26,085.;GPL6884;Graham,J.,Mann;graham.mann@sydney.edu.au;Melanoma Institute Australia;Poche Centre, 40 Rocklands Road;North Sydney;NSW;2060;Australia;NONE;26085;Reanalysis of: GSM1282639;1;19;22;Alive NSR;Female;Stage II;144,76;110,37
0,069295669;0,023956181;0,061084361;0;0;0,253918305;0,591745484;GSM1315905;melanoma AJCCstageIII TumourID125;Public on Aug 18 2014;Jan 28 2014;Aug 18 2014;RNA;1;melanoma lymph node, fresh frozen tissue (>80% tumor cell content, <30% necrosis);Homo sapiens;patient age at primary diagnosis (years): 53;patient sex: Male;patient age at stage iii sample banked (years): 56;survival from stage iii tumour banked (months): 9.04;survival from primary melanoma (months): 47.28;patient last status: Dead Melanoma;number of primary melanomas: 1;stage at primary diagnosis 5th edition: Stage II;Tissue samples were homogenized using a high-speed agitation polytron blender (Kinematica, Luzern, Switzerland) in the presence of Trizol.;Total RNA was extracted from 20-30mg of fresh frozen tissue.;total RNA;The RNA was isolated and purified with an RNeasy purification kit (Qiagen RNeasy purification kit- Qiagen Pty Ltd., Clifton Hill, Victoria, Australia) with DNAse I digestion on the column. The quality of the RNA preparations was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA, USA). RNA integrity scores were >8 for all samples analyzed.;biotin;cRNA amplification and labelling with biotin were performed using Illumina TotalPrep RNA amplification kit according to the manufacturer’s directions (Ambion, Inc., Austin, TX, USA) with 250ng total RNA as input material.;9606;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Quality control was performed on all chips using R/Bioconductor and the lumi package (www.bioconductor.org). Data normalization was performed using a variance-stabilizing transform (VST) and quantile normalization as implemented in the lumi package for R/Bioconductor. To reduce false positives, unexpressed genes (detection p-value >0.01) were removed, reducing the number of probes analysed from 48,802 to 26,085.;GPL6884;Graham,J.,Mann;graham.mann@sydney.edu.au;Melanoma Institute Australia;Poche Centre, 40 Rocklands Road;North Sydney;NSW;2060;Australia;NONE;26085;Reanalysis of: GSM1282626;1;53;56;Dead Melanoma;Male;Stage II;47,28;9,04
0;0,057045305;0,058768975;0;0;0,342573705;0,541612015;GSM1315906;melanoma AJCCstageIII TumourID360;Public on Aug 18 2014;Jan 28 2014;Aug 18 2014;RNA;1;melanoma lymph node, fresh frozen tissue (>80% tumor cell content, <30% necrosis);Homo sapiens;patient age at primary diagnosis (years): 52;patient sex: Female;patient age at stage iii sample banked (years): 53;survival from stage iii tumour banked (months): 11.31;survival from primary melanoma (months): 23.28;patient last status: Dead Melanoma;number of primary melanomas: 1;stage at primary diagnosis 5th edition: Stage II;Tissue samples were homogenized using a high-speed agitation polytron blender (Kinematica, Luzern, Switzerland) in the presence of Trizol.;Total RNA was extracted from 20-30mg of fresh frozen tissue.;total RNA;The RNA was isolated and purified with an RNeasy purification kit (Qiagen RNeasy purification kit- Qiagen Pty Ltd., Clifton Hill, Victoria, Australia) with DNAse I digestion on the column. The quality of the RNA preparations was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA, USA). RNA integrity scores were >8 for all samples analyzed.;biotin;cRNA amplification and labelling with biotin were performed using Illumina TotalPrep RNA amplification kit according to the manufacturer’s directions (Ambion, Inc., Austin, TX, USA) with 250ng total RNA as input material.;9606;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Quality control was performed on all chips using R/Bioconductor and the lumi package (www.bioconductor.org). Data normalization was performed using a variance-stabilizing transform (VST) and quantile normalization as implemented in the lumi package for R/Bioconductor. To reduce false positives, unexpressed genes (detection p-value >0.01) were removed, reducing the number of probes analysed from 48,802 to 26,085.;GPL6884;Graham,J.,Mann;graham.mann@sydney.edu.au;Melanoma Institute Australia;Poche Centre, 40 Rocklands Road;North Sydney;NSW;2060;Australia;NONE;26085;Reanalysis of: GSM1282662;1;52;53;Dead Melanoma;Female;Stage II;23,28;11,31
0,200086339;0;0;0,127073609;0,011712893;0;0,66112716;GSM1315907;melanoma AJCCstageIII TumourID277;Public on Aug 18 2014;Jan 28 2014;Aug 18 2014;RNA;1;melanoma lymph node, fresh frozen tissue (>80% tumor cell content, <30% necrosis);Homo sapiens;patient age at primary diagnosis (years): 51;patient sex: Male;patient age at stage iii sample banked (years): 52;survival from stage iii tumour banked (months): 95.11;survival from primary melanoma (months): 111.02;patient last status: Alive NSR;number of primary melanomas: 1;stage at primary diagnosis 5th edition: Stage I;Tissue samples were homogenized using a high-speed agitation polytron blender (Kinematica, Luzern, Switzerland) in the presence of Trizol.;Total RNA was extracted from 20-30mg of fresh frozen tissue.;total RNA;The RNA was isolated and purified with an RNeasy purification kit (Qiagen RNeasy purification kit- Qiagen Pty Ltd., Clifton Hill, Victoria, Australia) with DNAse I digestion on the column. The quality of the RNA preparations was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA, USA). RNA integrity scores were >8 for all samples analyzed.;biotin;cRNA amplification and labelling with biotin were performed using Illumina TotalPrep RNA amplification kit according to the manufacturer’s directions (Ambion, Inc., Austin, TX, USA) with 250ng total RNA as input material.;9606;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Quality control was performed on all chips using R/Bioconductor and the lumi package (www.bioconductor.org). Data normalization was performed using a variance-stabilizing transform (VST) and quantile normalization as implemented in the lumi package for R/Bioconductor. To reduce false positives, unexpressed genes (detection p-value >0.01) were removed, reducing the number of probes analysed from 48,802 to 26,085.;GPL6884;Graham,J.,Mann;graham.mann@sydney.edu.au;Melanoma Institute Australia;Poche Centre, 40 Rocklands Road;North Sydney;NSW;2060;Australia;NONE;26085;Reanalysis of: GSM1282650;1;51;52;Alive NSR;Male;Stage I;111,02;95,11
0,176622653;0,083437068;0,069199166;0;0;0,121182795;0,549558318;GSM1315908;melanoma AJCCstageIII TumourID23;Public on Aug 18 2014;Jan 28 2014;Aug 18 2014;RNA;1;melanoma lymph node, fresh frozen tissue (>80% tumor cell content, <30% necrosis);Homo sapiens;patient age at primary diagnosis (years): 47;patient sex: Male;patient age at stage iii sample banked (years): 51;survival from stage iii tumour banked (months): 96.62;survival from primary melanoma (months): 142.78;patient last status: Dead Melanoma;number of primary melanomas: 1;stage at primary diagnosis 5th edition: Stage II;Tissue samples were homogenized using a high-speed agitation polytron blender (Kinematica, Luzern, Switzerland) in the presence of Trizol.;Total RNA was extracted from 20-30mg of fresh frozen tissue.;total RNA;The RNA was isolated and purified with an RNeasy purification kit (Qiagen RNeasy purification kit- Qiagen Pty Ltd., Clifton Hill, Victoria, Australia) with DNAse I digestion on the column. The quality of the RNA preparations was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA, USA). RNA integrity scores were >8 for all samples analyzed.;biotin;cRNA amplification and labelling with biotin were performed using Illumina TotalPrep RNA amplification kit according to the manufacturer’s directions (Ambion, Inc., Austin, TX, USA) with 250ng total RNA as input material.;9606;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Quality control was performed on all chips using R/Bioconductor and the lumi package (www.bioconductor.org). Data normalization was performed using a variance-stabilizing transform (VST) and quantile normalization as implemented in the lumi package for R/Bioconductor. To reduce false positives, unexpressed genes (detection p-value >0.01) were removed, reducing the number of probes analysed from 48,802 to 26,085.;GPL6884;Graham,J.,Mann;graham.mann@sydney.edu.au;Melanoma Institute Australia;Poche Centre, 40 Rocklands Road;North Sydney;NSW;2060;Australia;NONE;26085;Reanalysis of: GSM1282596;1;47;51;Dead Melanoma;Male;Stage II;142,78;96,62
0;0,04574709;0,007629929;0;0;0,478919691;0,46770329;GSM1315909;melanoma AJCCstageIII TumourID15;Public on Aug 18 2014;Jan 28 2014;Aug 18 2014;RNA;1;melanoma lymph node, fresh frozen tissue (>80% tumor cell content, <30% necrosis);Homo sapiens;patient age at primary diagnosis (years): 61;patient sex: Male;patient age at stage iii sample banked (years): 64;survival from stage iii tumour banked (months): 16.67;survival from primary melanoma (months): 51.35;patient last status: Dead Melanoma;number of primary melanomas: 1;stage at primary diagnosis 5th edition: Stage I;Tissue samples were homogenized using a high-speed agitation polytron blender (Kinematica, Luzern, Switzerland) in the presence of Trizol.;Total RNA was extracted from 20-30mg of fresh frozen tissue.;total RNA;The RNA was isolated and purified with an RNeasy purification kit (Qiagen RNeasy purification kit- Qiagen Pty Ltd., Clifton Hill, Victoria, Australia) with DNAse I digestion on the column. The quality of the RNA preparations was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA, USA). RNA integrity scores were >8 for all samples analyzed.;biotin;cRNA amplification and labelling with biotin were performed using Illumina TotalPrep RNA amplification kit according to the manufacturer’s directions (Ambion, Inc., Austin, TX, USA) with 250ng total RNA as input material.;9606;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Quality control was performed on all chips using R/Bioconductor and the lumi package (www.bioconductor.org). Data normalization was performed using a variance-stabilizing transform (VST) and quantile normalization as implemented in the lumi package for R/Bioconductor. To reduce false positives, unexpressed genes (detection p-value >0.01) were removed, reducing the number of probes analysed from 48,802 to 26,085.;GPL6884;Graham,J.,Mann;graham.mann@sydney.edu.au;Melanoma Institute Australia;Poche Centre, 40 Rocklands Road;North Sydney;NSW;2060;Australia;NONE;26085;Reanalysis of: GSM1282593;1;61;64;Dead Melanoma;Male;Stage I;51,35;16,67
0,124516945;0;0;0,111119829;0,005197932;0;0,759165294;GSM1315910;melanoma AJCCstageIII TumourID17;Public on Aug 18 2014;Jan 28 2014;Aug 18 2014;RNA;1;melanoma lymph node, fresh frozen tissue (>80% tumor cell content, <30% necrosis);Homo sapiens;patient age at primary diagnosis (years): 46;patient sex: Female;patient age at stage iii sample banked (years): 52;survival from stage iii tumour banked (months): 152.15;survival from primary melanoma (months): 231.91;patient last status: Alive NSR;number of primary melanomas: 1;stage at primary diagnosis 5th edition: Stage I;Tissue samples were homogenized using a high-speed agitation polytron blender (Kinematica, Luzern, Switzerland) in the presence of Trizol.;Total RNA was extracted from 20-30mg of fresh frozen tissue.;total RNA;The RNA was isolated and purified with an RNeasy purification kit (Qiagen RNeasy purification kit- Qiagen Pty Ltd., Clifton Hill, Victoria, Australia) with DNAse I digestion on the column. The quality of the RNA preparations was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA, USA). RNA integrity scores were >8 for all samples analyzed.;biotin;cRNA amplification and labelling with biotin were performed using Illumina TotalPrep RNA amplification kit according to the manufacturer’s directions (Ambion, Inc., Austin, TX, USA) with 250ng total RNA as input material.;9606;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Quality control was performed on all chips using R/Bioconductor and the lumi package (www.bioconductor.org). Data normalization was performed using a variance-stabilizing transform (VST) and quantile normalization as implemented in the lumi package for R/Bioconductor. To reduce false positives, unexpressed genes (detection p-value >0.01) were removed, reducing the number of probes analysed from 48,802 to 26,085.;GPL6884;Graham,J.,Mann;graham.mann@sydney.edu.au;Melanoma Institute Australia;Poche Centre, 40 Rocklands Road;North Sydney;NSW;2060;Australia;NONE;26085;Reanalysis of: GSM1282595;1;46;52;Alive NSR;Female;Stage I;231,91;152,15
0,044195004;0,090949123;0,073471927;0;0;0,270934837;0,520449108;GSM1315911;melanoma AJCCstageIII TumourID340;Public on Aug 18 2014;Jan 28 2014;Aug 18 2014;RNA;1;melanoma lymph node, fresh frozen tissue (>80% tumor cell content, <30% necrosis);Homo sapiens;patient age at primary diagnosis (years): 61;patient sex: Male;patient age at stage iii sample banked (years): 75;survival from stage iii tumour banked (months): 7.73;survival from primary melanoma (months): 182.83;patient last status: Dead Melanoma;number of primary melanomas: 1;stage at primary diagnosis 5th edition: Stage I;Tissue samples were homogenized using a high-speed agitation polytron blender (Kinematica, Luzern, Switzerland) in the presence of Trizol.;Total RNA was extracted from 20-30mg of fresh frozen tissue.;total RNA;The RNA was isolated and purified with an RNeasy purification kit (Qiagen RNeasy purification kit- Qiagen Pty Ltd., Clifton Hill, Victoria, Australia) with DNAse I digestion on the column. The quality of the RNA preparations was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA, USA). RNA integrity scores were >8 for all samples analyzed.;biotin;cRNA amplification and labelling with biotin were performed using Illumina TotalPrep RNA amplification kit according to the manufacturer’s directions (Ambion, Inc., Austin, TX, USA) with 250ng total RNA as input material.;9606;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Quality control was performed on all chips using R/Bioconductor and the lumi package (www.bioconductor.org). Data normalization was performed using a variance-stabilizing transform (VST) and quantile normalization as implemented in the lumi package for R/Bioconductor. To reduce false positives, unexpressed genes (detection p-value >0.01) were removed, reducing the number of probes analysed from 48,802 to 26,085.;GPL6884;Graham,J.,Mann;graham.mann@sydney.edu.au;Melanoma Institute Australia;Poche Centre, 40 Rocklands Road;North Sydney;NSW;2060;Australia;NONE;26085;Reanalysis of: GSM1282656;1;61;75;Dead Melanoma;Male;Stage I;182,83;7,73
0,065368495;0,043945686;0,090958802;0;0;0,292990986;0,506736031;GSM1315912;melanoma AJCCstageIII TumourID120;Public on Aug 18 2014;Jan 28 2014;Aug 18 2014;RNA;1;melanoma lymph node, fresh frozen tissue (>80% tumor cell content, <30% necrosis);Homo sapiens;patient age at primary diagnosis (years): 84;patient sex: Female;patient age at stage iii sample banked (years): 87;survival from stage iii tumour banked (months): 16.11;survival from primary melanoma (months): 49.71;patient last status: Dead Melanoma;number of primary melanomas: 1;stage at primary diagnosis 5th edition: Stage I;Tissue samples were homogenized using a high-speed agitation polytron blender (Kinematica, Luzern, Switzerland) in the presence of Trizol.;Total RNA was extracted from 20-30mg of fresh frozen tissue.;total RNA;The RNA was isolated and purified with an RNeasy purification kit (Qiagen RNeasy purification kit- Qiagen Pty Ltd., Clifton Hill, Victoria, Australia) with DNAse I digestion on the column. The quality of the RNA preparations was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA, USA). RNA integrity scores were >8 for all samples analyzed.;biotin;cRNA amplification and labelling with biotin were performed using Illumina TotalPrep RNA amplification kit according to the manufacturer’s directions (Ambion, Inc., Austin, TX, USA) with 250ng total RNA as input material.;9606;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Quality control was performed on all chips using R/Bioconductor and the lumi package (www.bioconductor.org). Data normalization was performed using a variance-stabilizing transform (VST) and quantile normalization as implemented in the lumi package for R/Bioconductor. To reduce false positives, unexpressed genes (detection p-value >0.01) were removed, reducing the number of probes analysed from 48,802 to 26,085.;GPL6884;Graham,J.,Mann;graham.mann@sydney.edu.au;Melanoma Institute Australia;Poche Centre, 40 Rocklands Road;North Sydney;NSW;2060;Australia;NONE;26085;Reanalysis of: GSM1282625;1;84;87;Dead Melanoma;Female;Stage I;49,71;16,11
0,1655891;0,006422029;0,066307778;0,135810683;0,079779379;0;0,54609103;GSM1315913;melanoma AJCCstageIII TumourID51;Public on Aug 18 2014;Jan 28 2014;Aug 18 2014;RNA;1;melanoma lymph node, fresh frozen tissue (>80% tumor cell content, <30% necrosis);Homo sapiens;patient age at primary diagnosis (years): 44;patient sex: Female;patient age at stage iii sample banked (years): 44;survival from stage iii tumour banked (months): 128.91;survival from primary melanoma (months): 129.99;patient last status: Alive NSR;number of primary melanomas: 1;stage at primary diagnosis 5th edition: Stage III;Tissue samples were homogenized using a high-speed agitation polytron blender (Kinematica, Luzern, Switzerland) in the presence of Trizol.;Total RNA was extracted from 20-30mg of fresh frozen tissue.;total RNA;The RNA was isolated and purified with an RNeasy purification kit (Qiagen RNeasy purification kit- Qiagen Pty Ltd., Clifton Hill, Victoria, Australia) with DNAse I digestion on the column. The quality of the RNA preparations was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA, USA). RNA integrity scores were >8 for all samples analyzed.;biotin;cRNA amplification and labelling with biotin were performed using Illumina TotalPrep RNA amplification kit according to the manufacturer’s directions (Ambion, Inc., Austin, TX, USA) with 250ng total RNA as input material.;9606;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Quality control was performed on all chips using R/Bioconductor and the lumi package (www.bioconductor.org). Data normalization was performed using a variance-stabilizing transform (VST) and quantile normalization as implemented in the lumi package for R/Bioconductor. To reduce false positives, unexpressed genes (detection p-value >0.01) were removed, reducing the number of probes analysed from 48,802 to 26,085.;GPL6884;Graham,J.,Mann;graham.mann@sydney.edu.au;Melanoma Institute Australia;Poche Centre, 40 Rocklands Road;North Sydney;NSW;2060;Australia;NONE;26085;Reanalysis of: GSM1282607;1;44;44;Alive NSR;Female;Stage III;129,99;128,91
0,058267652;0,033078622;0,070012868;0;0;0,388480907;0,45015995;GSM1315914;melanoma AJCCstageIII TumourID205;Public on Aug 18 2014;Jan 28 2014;Aug 18 2014;RNA;1;melanoma lymph node, fresh frozen tissue (>80% tumor cell content, <30% necrosis);Homo sapiens;patient age at primary diagnosis (years): 64;patient sex: Male;patient age at stage iii sample banked (years): 72;survival from stage iii tumour banked (months): 7.92;survival from primary melanoma (months): 110.76;patient last status: Dead Melanoma;number of primary melanomas: 1;stage at primary diagnosis 5th edition: Stage I;Tissue samples were homogenized using a high-speed agitation polytron blender (Kinematica, Luzern, Switzerland) in the presence of Trizol.;Total RNA was extracted from 20-30mg of fresh frozen tissue.;total RNA;The RNA was isolated and purified with an RNeasy purification kit (Qiagen RNeasy purification kit- Qiagen Pty Ltd., Clifton Hill, Victoria, Australia) with DNAse I digestion on the column. The quality of the RNA preparations was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA, USA). RNA integrity scores were >8 for all samples analyzed.;biotin;cRNA amplification and labelling with biotin were performed using Illumina TotalPrep RNA amplification kit according to the manufacturer’s directions (Ambion, Inc., Austin, TX, USA) with 250ng total RNA as input material.;9606;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Quality control was performed on all chips using R/Bioconductor and the lumi package (www.bioconductor.org). Data normalization was performed using a variance-stabilizing transform (VST) and quantile normalization as implemented in the lumi package for R/Bioconductor. To reduce false positives, unexpressed genes (detection p-value >0.01) were removed, reducing the number of probes analysed from 48,802 to 26,085.;GPL6884;Graham,J.,Mann;graham.mann@sydney.edu.au;Melanoma Institute Australia;Poche Centre, 40 Rocklands Road;North Sydney;NSW;2060;Australia;NONE;26085;Reanalysis of: GSM1282638;1;64;72;Dead Melanoma;Male;Stage I;110,76;7,92
0,204948215;0;0,013258016;0,166649299;0,043409469;0;0,571735001;GSM1315915;melanoma AJCCstageIII TumourID49;Public on Aug 18 2014;Jan 28 2014;Aug 18 2014;RNA;1;melanoma lymph node, fresh frozen tissue (>80% tumor cell content, <30% necrosis);Homo sapiens;patient age at primary diagnosis (years): 31;patient sex: Male;patient age at stage iii sample banked (years): 31;survival from stage iii tumour banked (months): 100.08;survival from primary melanoma (months): 101.16;patient last status: Alive NSR;number of primary melanomas: 1;stage at primary diagnosis 5th edition: Stage III;Tissue samples were homogenized using a high-speed agitation polytron blender (Kinematica, Luzern, Switzerland) in the presence of Trizol.;Total RNA was extracted from 20-30mg of fresh frozen tissue.;total RNA;The RNA was isolated and purified with an RNeasy purification kit (Qiagen RNeasy purification kit- Qiagen Pty Ltd., Clifton Hill, Victoria, Australia) with DNAse I digestion on the column. The quality of the RNA preparations was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA, USA). RNA integrity scores were >8 for all samples analyzed.;biotin;cRNA amplification and labelling with biotin were performed using Illumina TotalPrep RNA amplification kit according to the manufacturer’s directions (Ambion, Inc., Austin, TX, USA) with 250ng total RNA as input material.;9606;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Quality control was performed on all chips using R/Bioconductor and the lumi package (www.bioconductor.org). Data normalization was performed using a variance-stabilizing transform (VST) and quantile normalization as implemented in the lumi package for R/Bioconductor. To reduce false positives, unexpressed genes (detection p-value >0.01) were removed, reducing the number of probes analysed from 48,802 to 26,085.;GPL6884;Graham,J.,Mann;graham.mann@sydney.edu.au;Melanoma Institute Australia;Poche Centre, 40 Rocklands Road;North Sydney;NSW;2060;Australia;NONE;26085;Reanalysis of: GSM1282606;1;31;31;Alive NSR;Male;Stage III;101,16;100,08
0;0,029557595;0,019661599;0,002800163;0;0,491345219;0,456635424;GSM1315916;melanoma AJCCstageIII TumourID119;Public on Aug 18 2014;Jan 28 2014;Aug 18 2014;RNA;1;melanoma lymph node, fresh frozen tissue (>80% tumor cell content, <30% necrosis);Homo sapiens;patient age at primary diagnosis (years): 63;patient sex: Male;patient age at stage iii sample banked (years): 65;survival from stage iii tumour banked (months): 0.89;survival from primary melanoma (months): 21.83;patient last status: Dead Melanoma;number of primary melanomas: 2;stage at primary diagnosis 5th edition: Stage II;Tissue samples were homogenized using a high-speed agitation polytron blender (Kinematica, Luzern, Switzerland) in the presence of Trizol.;Total RNA was extracted from 20-30mg of fresh frozen tissue.;total RNA;The RNA was isolated and purified with an RNeasy purification kit (Qiagen RNeasy purification kit- Qiagen Pty Ltd., Clifton Hill, Victoria, Australia) with DNAse I digestion on the column. The quality of the RNA preparations was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA, USA). RNA integrity scores were >8 for all samples analyzed.;biotin;cRNA amplification and labelling with biotin were performed using Illumina TotalPrep RNA amplification kit according to the manufacturer’s directions (Ambion, Inc., Austin, TX, USA) with 250ng total RNA as input material.;9606;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Quality control was performed on all chips using R/Bioconductor and the lumi package (www.bioconductor.org). Data normalization was performed using a variance-stabilizing transform (VST) and quantile normalization as implemented in the lumi package for R/Bioconductor. To reduce false positives, unexpressed genes (detection p-value >0.01) were removed, reducing the number of probes analysed from 48,802 to 26,085.;GPL6884;Graham,J.,Mann;graham.mann@sydney.edu.au;Melanoma Institute Australia;Poche Centre, 40 Rocklands Road;North Sydney;NSW;2060;Australia;NONE;26085;Reanalysis of: GSM1282624;2;63;65;Dead Melanoma;Male;Stage II;21,83;0,89
0,122462706;0;0,00504886;0;0;0,347156357;0,525332077;GSM1315917;melanoma AJCCstageIII TumourID179;Public on Aug 18 2014;Jan 28 2014;Aug 18 2014;RNA;1;melanoma lymph node, fresh frozen tissue (>80% tumor cell content, <30% necrosis);Homo sapiens;patient age at primary diagnosis (years): 58;patient sex: Male;patient age at stage iii sample banked (years): 59;survival from stage iii tumour banked (months): 23.47;survival from primary melanoma (months): 36.62;patient last status: Dead Melanoma;number of primary melanomas: 1;stage at primary diagnosis 5th edition: Stage III;Tissue samples were homogenized using a high-speed agitation polytron blender (Kinematica, Luzern, Switzerland) in the presence of Trizol.;Total RNA was extracted from 20-30mg of fresh frozen tissue.;total RNA;The RNA was isolated and purified with an RNeasy purification kit (Qiagen RNeasy purification kit- Qiagen Pty Ltd., Clifton Hill, Victoria, Australia) with DNAse I digestion on the column. The quality of the RNA preparations was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA, USA). RNA integrity scores were >8 for all samples analyzed.;biotin;cRNA amplification and labelling with biotin were performed using Illumina TotalPrep RNA amplification kit according to the manufacturer’s directions (Ambion, Inc., Austin, TX, USA) with 250ng total RNA as input material.;9606;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Quality control was performed on all chips using R/Bioconductor and the lumi package (www.bioconductor.org). Data normalization was performed using a variance-stabilizing transform (VST) and quantile normalization as implemented in the lumi package for R/Bioconductor. To reduce false positives, unexpressed genes (detection p-value >0.01) were removed, reducing the number of probes analysed from 48,802 to 26,085.;GPL6884;Graham,J.,Mann;graham.mann@sydney.edu.au;Melanoma Institute Australia;Poche Centre, 40 Rocklands Road;North Sydney;NSW;2060;Australia;NONE;26085;Reanalysis of: GSM1282634;1;58;59;Dead Melanoma;Male;Stage III;36,62;23,47
0,332281692;0;0;0;0;0;0,667718308;GSM1315918;melanoma AJCCstageIII TumourID349;Public on Aug 18 2014;Jan 28 2014;Aug 18 2014;RNA;1;melanoma lymph node, fresh frozen tissue (>80% tumor cell content, <30% necrosis);Homo sapiens;patient age at primary diagnosis (years): 56;patient sex: Male;patient age at stage iii sample banked (years): 67;survival from stage iii tumour banked (months): 92.35;survival from primary melanoma (months): 217.94;patient last status: Alive NSR;number of primary melanomas: 1;stage at primary diagnosis 5th edition: Stage Unknown;Tissue samples were homogenized using a high-speed agitation polytron blender (Kinematica, Luzern, Switzerland) in the presence of Trizol.;Total RNA was extracted from 20-30mg of fresh frozen tissue.;total RNA;The RNA was isolated and purified with an RNeasy purification kit (Qiagen RNeasy purification kit- Qiagen Pty Ltd., Clifton Hill, Victoria, Australia) with DNAse I digestion on the column. The quality of the RNA preparations was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA, USA). RNA integrity scores were >8 for all samples analyzed.;biotin;cRNA amplification and labelling with biotin were performed using Illumina TotalPrep RNA amplification kit according to the manufacturer’s directions (Ambion, Inc., Austin, TX, USA) with 250ng total RNA as input material.;9606;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Quality control was performed on all chips using R/Bioconductor and the lumi package (www.bioconductor.org). Data normalization was performed using a variance-stabilizing transform (VST) and quantile normalization as implemented in the lumi package for R/Bioconductor. To reduce false positives, unexpressed genes (detection p-value >0.01) were removed, reducing the number of probes analysed from 48,802 to 26,085.;GPL6884;Graham,J.,Mann;graham.mann@sydney.edu.au;Melanoma Institute Australia;Poche Centre, 40 Rocklands Road;North Sydney;NSW;2060;Australia;NONE;26085;Reanalysis of: GSM1282658;1;56;67;Alive NSR;Male;Stage Unknown;217,94;92,35
0,138356061;0;0,044626501;0,010101239;0,001272681;0,275440012;0,530203506;GSM1315919;melanoma AJCCstageIII TumourID334;Public on Aug 18 2014;Jan 28 2014;Aug 18 2014;RNA;1;melanoma lymph node, fresh frozen tissue (>80% tumor cell content, <30% necrosis);Homo sapiens;patient age at primary diagnosis (years): 48;patient sex: Female;patient age at stage iii sample banked (years): 57;survival from stage iii tumour banked (months): 10.72;survival from primary melanoma (months): 120.13;patient last status: Dead Melanoma;number of primary melanomas: 1;stage at primary diagnosis 5th edition: Stage II;Tissue samples were homogenized using a high-speed agitation polytron blender (Kinematica, Luzern, Switzerland) in the presence of Trizol.;Total RNA was extracted from 20-30mg of fresh frozen tissue.;total RNA;The RNA was isolated and purified with an RNeasy purification kit (Qiagen RNeasy purification kit- Qiagen Pty Ltd., Clifton Hill, Victoria, Australia) with DNAse I digestion on the column. The quality of the RNA preparations was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA, USA). RNA integrity scores were >8 for all samples analyzed.;biotin;cRNA amplification and labelling with biotin were performed using Illumina TotalPrep RNA amplification kit according to the manufacturer’s directions (Ambion, Inc., Austin, TX, USA) with 250ng total RNA as input material.;9606;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Quality control was performed on all chips using R/Bioconductor and the lumi package (www.bioconductor.org). Data normalization was performed using a variance-stabilizing transform (VST) and quantile normalization as implemented in the lumi package for R/Bioconductor. To reduce false positives, unexpressed genes (detection p-value >0.01) were removed, reducing the number of probes analysed from 48,802 to 26,085.;GPL6884;Graham,J.,Mann;graham.mann@sydney.edu.au;Melanoma Institute Australia;Poche Centre, 40 Rocklands Road;North Sydney;NSW;2060;Australia;NONE;26085;Reanalysis of: GSM1282655;1;48;57;Dead Melanoma;Female;Stage II;120,13;10,72
0,006426307;0,029361623;0,036733541;0;0;0,56602776;0,361450769;GSM1315920;melanoma AJCCstageIII TumourID83;Public on Aug 18 2014;Jan 28 2014;Aug 18 2014;RNA;1;melanoma lymph node, fresh frozen tissue (>80% tumor cell content, <30% necrosis);Homo sapiens;patient age at primary diagnosis (years): 69;patient sex: Male;patient age at stage iii sample banked (years): 70;survival from stage iii tumour banked (months): 7.66;survival from primary melanoma (months): 8.71;patient last status: Dead Melanoma;number of primary melanomas: 1;stage at primary diagnosis 5th edition: Stage III;Tissue samples were homogenized using a high-speed agitation polytron blender (Kinematica, Luzern, Switzerland) in the presence of Trizol.;Total RNA was extracted from 20-30mg of fresh frozen tissue.;total RNA;The RNA was isolated and purified with an RNeasy purification kit (Qiagen RNeasy purification kit- Qiagen Pty Ltd., Clifton Hill, Victoria, Australia) with DNAse I digestion on the column. The quality of the RNA preparations was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA, USA). RNA integrity scores were >8 for all samples analyzed.;biotin;cRNA amplification and labelling with biotin were performed using Illumina TotalPrep RNA amplification kit according to the manufacturer’s directions (Ambion, Inc., Austin, TX, USA) with 250ng total RNA as input material.;9606;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Quality control was performed on all chips using R/Bioconductor and the lumi package (www.bioconductor.org). Data normalization was performed using a variance-stabilizing transform (VST) and quantile normalization as implemented in the lumi package for R/Bioconductor. To reduce false positives, unexpressed genes (detection p-value >0.01) were removed, reducing the number of probes analysed from 48,802 to 26,085.;GPL6884;Graham,J.,Mann;graham.mann@sydney.edu.au;Melanoma Institute Australia;Poche Centre, 40 Rocklands Road;North Sydney;NSW;2060;Australia;NONE;26085;Reanalysis of: GSM1282617;1;69;70;Dead Melanoma;Male;Stage III;8,71;7,66
0,160895788;0;0;0;0,015324378;0;0,823779834;GSM1315921;melanoma AJCCstageIII TumourID343;Public on Aug 18 2014;Jan 28 2014;Aug 18 2014;RNA;1;melanoma lymph node, fresh frozen tissue (>80% tumor cell content, <30% necrosis);Homo sapiens;patient age at primary diagnosis (years): 76;patient sex: Male;patient age at stage iii sample banked (years): 77;survival from stage iii tumour banked (months): 6.35;survival from primary melanoma (months): 19.79;patient last status: Dead Melanoma;number of primary melanomas: 1;stage at primary diagnosis 5th edition: Stage II;Tissue samples were homogenized using a high-speed agitation polytron blender (Kinematica, Luzern, Switzerland) in the presence of Trizol.;Total RNA was extracted from 20-30mg of fresh frozen tissue.;total RNA;The RNA was isolated and purified with an RNeasy purification kit (Qiagen RNeasy purification kit- Qiagen Pty Ltd., Clifton Hill, Victoria, Australia) with DNAse I digestion on the column. The quality of the RNA preparations was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA, USA). RNA integrity scores were >8 for all samples analyzed.;biotin;cRNA amplification and labelling with biotin were performed using Illumina TotalPrep RNA amplification kit according to the manufacturer’s directions (Ambion, Inc., Austin, TX, USA) with 250ng total RNA as input material.;9606;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Quality control was performed on all chips using R/Bioconductor and the lumi package (www.bioconductor.org). Data normalization was performed using a variance-stabilizing transform (VST) and quantile normalization as implemented in the lumi package for R/Bioconductor. To reduce false positives, unexpressed genes (detection p-value >0.01) were removed, reducing the number of probes analysed from 48,802 to 26,085.;GPL6884;Graham,J.,Mann;graham.mann@sydney.edu.au;Melanoma Institute Australia;Poche Centre, 40 Rocklands Road;North Sydney;NSW;2060;Australia;NONE;26085;Reanalysis of: GSM1282657;1;76;77;Dead Melanoma;Male;Stage II;19,79;6,35
0,197139847;0;0;0,040846787;0,031481081;0;0,730532284;GSM1315922;melanoma AJCCstageIII TumourID52;Public on Aug 18 2014;Jan 28 2014;Aug 18 2014;RNA;1;melanoma lymph node, fresh frozen tissue (>80% tumor cell content, <30% necrosis);Homo sapiens;patient age at primary diagnosis (years): 54;patient sex: Female;patient age at stage iii sample banked (years): 55;survival from stage iii tumour banked (months): 5.56;survival from primary melanoma (months): 19.76;patient last status: Dead Melanoma;number of primary melanomas: 1;stage at primary diagnosis 5th edition: Stage III;Tissue samples were homogenized using a high-speed agitation polytron blender (Kinematica, Luzern, Switzerland) in the presence of Trizol.;Total RNA was extracted from 20-30mg of fresh frozen tissue.;total RNA;The RNA was isolated and purified with an RNeasy purification kit (Qiagen RNeasy purification kit- Qiagen Pty Ltd., Clifton Hill, Victoria, Australia) with DNAse I digestion on the column. The quality of the RNA preparations was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA, USA). RNA integrity scores were >8 for all samples analyzed.;biotin;cRNA amplification and labelling with biotin were performed using Illumina TotalPrep RNA amplification kit according to the manufacturer’s directions (Ambion, Inc., Austin, TX, USA) with 250ng total RNA as input material.;9606;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Quality control was performed on all chips using R/Bioconductor and the lumi package (www.bioconductor.org). Data normalization was performed using a variance-stabilizing transform (VST) and quantile normalization as implemented in the lumi package for R/Bioconductor. To reduce false positives, unexpressed genes (detection p-value >0.01) were removed, reducing the number of probes analysed from 48,802 to 26,085.;GPL6884;Graham,J.,Mann;graham.mann@sydney.edu.au;Melanoma Institute Australia;Poche Centre, 40 Rocklands Road;North Sydney;NSW;2060;Australia;NONE;26085;Reanalysis of: GSM1282608;1;54;55;Dead Melanoma;Female;Stage III;19,76;5,56
0,056786459;0,03953394;0;0,062314904;0,012958494;0,123570575;0,704835628;GSM1315923;melanoma AJCCstageIII TumourID356;Public on Aug 18 2014;Jan 28 2014;Aug 18 2014;RNA;1;melanoma lymph node, fresh frozen tissue (>80% tumor cell content, <30% necrosis);Homo sapiens;patient age at primary diagnosis (years): 82;patient sex: Male;patient age at stage iii sample banked (years): 85;survival from stage iii tumour banked (months): 35.08;survival from primary melanoma (months): 74.76;patient last status: Dead Not Melanoma;number of primary melanomas: 1;stage at primary diagnosis 5th edition: Stage II;Tissue samples were homogenized using a high-speed agitation polytron blender (Kinematica, Luzern, Switzerland) in the presence of Trizol.;Total RNA was extracted from 20-30mg of fresh frozen tissue.;total RNA;The RNA was isolated and purified with an RNeasy purification kit (Qiagen RNeasy purification kit- Qiagen Pty Ltd., Clifton Hill, Victoria, Australia) with DNAse I digestion on the column. The quality of the RNA preparations was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA, USA). RNA integrity scores were >8 for all samples analyzed.;biotin;cRNA amplification and labelling with biotin were performed using Illumina TotalPrep RNA amplification kit according to the manufacturer’s directions (Ambion, Inc., Austin, TX, USA) with 250ng total RNA as input material.;9606;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Quality control was performed on all chips using R/Bioconductor and the lumi package (www.bioconductor.org). Data normalization was performed using a variance-stabilizing transform (VST) and quantile normalization as implemented in the lumi package for R/Bioconductor. To reduce false positives, unexpressed genes (detection p-value >0.01) were removed, reducing the number of probes analysed from 48,802 to 26,085.;GPL6884;Graham,J.,Mann;graham.mann@sydney.edu.au;Melanoma Institute Australia;Poche Centre, 40 Rocklands Road;North Sydney;NSW;2060;Australia;NONE;26085;Reanalysis of: GSM1282661;1;82;85;Dead Not Melanoma;Male;Stage II;74,76;35,08
0,069010137;0;0;0,119439306;0,061412408;0;0,750138149;GSM1315924;melanoma AJCCstageIII TumourID28;Public on Aug 18 2014;Jan 28 2014;Aug 18 2014;RNA;1;melanoma lymph node, fresh frozen tissue (>80% tumor cell content, <30% necrosis);Homo sapiens;patient age at primary diagnosis (years): 79;patient sex: Male;patient age at stage iii sample banked (years): 80;survival from stage iii tumour banked (months): 72.46;survival from primary melanoma (months): 79.79;patient last status: Alive NSR;number of primary melanomas: 1;stage at primary diagnosis 5th edition: Stage I;Tissue samples were homogenized using a high-speed agitation polytron blender (Kinematica, Luzern, Switzerland) in the presence of Trizol.;Total RNA was extracted from 20-30mg of fresh frozen tissue.;total RNA;The RNA was isolated and purified with an RNeasy purification kit (Qiagen RNeasy purification kit- Qiagen Pty Ltd., Clifton Hill, Victoria, Australia) with DNAse I digestion on the column. The quality of the RNA preparations was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA, USA). RNA integrity scores were >8 for all samples analyzed.;biotin;cRNA amplification and labelling with biotin were performed using Illumina TotalPrep RNA amplification kit according to the manufacturer’s directions (Ambion, Inc., Austin, TX, USA) with 250ng total RNA as input material.;9606;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Quality control was performed on all chips using R/Bioconductor and the lumi package (www.bioconductor.org). Data normalization was performed using a variance-stabilizing transform (VST) and quantile normalization as implemented in the lumi package for R/Bioconductor. To reduce false positives, unexpressed genes (detection p-value >0.01) were removed, reducing the number of probes analysed from 48,802 to 26,085.;GPL6884;Graham,J.,Mann;graham.mann@sydney.edu.au;Melanoma Institute Australia;Poche Centre, 40 Rocklands Road;North Sydney;NSW;2060;Australia;NONE;26085;Reanalysis of: GSM1282598;1;79;80;Alive NSR;Male;Stage I;79,79;72,46
0,15574212;0,021017954;0;0,082643607;0,018521025;0,291386594;0,4306887;GSM1315925;melanoma AJCCstageIII TumourID385;Public on Aug 18 2014;Jan 28 2014;Aug 18 2014;RNA;1;melanoma lymph node, fresh frozen tissue (>80% tumor cell content, <30% necrosis);Homo sapiens;patient age at primary diagnosis (years): 50;patient sex: Male;patient age at stage iii sample banked (years): 54;survival from stage iii tumour banked (months): 57.47;survival from primary melanoma (months): 99.55;patient last status: Alive NSR;number of primary melanomas: 1;stage at primary diagnosis 5th edition: Stage II;Tissue samples were homogenized using a high-speed agitation polytron blender (Kinematica, Luzern, Switzerland) in the presence of Trizol.;Total RNA was extracted from 20-30mg of fresh frozen tissue.;total RNA;The RNA was isolated and purified with an RNeasy purification kit (Qiagen RNeasy purification kit- Qiagen Pty Ltd., Clifton Hill, Victoria, Australia) with DNAse I digestion on the column. The quality of the RNA preparations was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA, USA). RNA integrity scores were >8 for all samples analyzed.;biotin;cRNA amplification and labelling with biotin were performed using Illumina TotalPrep RNA amplification kit according to the manufacturer’s directions (Ambion, Inc., Austin, TX, USA) with 250ng total RNA as input material.;9606;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Quality control was performed on all chips using R/Bioconductor and the lumi package (www.bioconductor.org). Data normalization was performed using a variance-stabilizing transform (VST) and quantile normalization as implemented in the lumi package for R/Bioconductor. To reduce false positives, unexpressed genes (detection p-value >0.01) were removed, reducing the number of probes analysed from 48,802 to 26,085.;GPL6884;Graham,J.,Mann;graham.mann@sydney.edu.au;Melanoma Institute Australia;Poche Centre, 40 Rocklands Road;North Sydney;NSW;2060;Australia;NONE;26085;Reanalysis of: GSM1282664;1;50;54;Alive NSR;Male;Stage II;99,55;57,47
0,030639557;0,029041247;0,008348459;0;0;0,522313572;0,409657165;GSM1315926;melanoma AJCCstageIII TumourID201;Public on Aug 18 2014;Jan 28 2014;Aug 18 2014;RNA;1;melanoma lymph node, fresh frozen tissue (>80% tumor cell content, <30% necrosis);Homo sapiens;patient age at primary diagnosis (years): 57;patient sex: Female;patient age at stage iii sample banked (years): 57;survival from stage iii tumour banked (months): 5.98;survival from primary melanoma (months): 10.19;patient last status: Alive with Melanoma;number of primary melanomas: 1;stage at primary diagnosis 5th edition: Stage III;Tissue samples were homogenized using a high-speed agitation polytron blender (Kinematica, Luzern, Switzerland) in the presence of Trizol.;Total RNA was extracted from 20-30mg of fresh frozen tissue.;total RNA;The RNA was isolated and purified with an RNeasy purification kit (Qiagen RNeasy purification kit- Qiagen Pty Ltd., Clifton Hill, Victoria, Australia) with DNAse I digestion on the column. The quality of the RNA preparations was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA, USA). RNA integrity scores were >8 for all samples analyzed.;biotin;cRNA amplification and labelling with biotin were performed using Illumina TotalPrep RNA amplification kit according to the manufacturer’s directions (Ambion, Inc., Austin, TX, USA) with 250ng total RNA as input material.;9606;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Quality control was performed on all chips using R/Bioconductor and the lumi package (www.bioconductor.org). Data normalization was performed using a variance-stabilizing transform (VST) and quantile normalization as implemented in the lumi package for R/Bioconductor. To reduce false positives, unexpressed genes (detection p-value >0.01) were removed, reducing the number of probes analysed from 48,802 to 26,085.;GPL6884;Graham,J.,Mann;graham.mann@sydney.edu.au;Melanoma Institute Australia;Poche Centre, 40 Rocklands Road;North Sydney;NSW;2060;Australia;NONE;26085;Reanalysis of: GSM1282637;1;57;57;Alive with Melanoma;Female;Stage III;10,19;5,98
0,14851863;0;0;0,050038989;0,007051655;0,129933898;0,664456829;GSM1315927;melanoma AJCCstageIII TumourID288;Public on Aug 18 2014;Jan 28 2014;Aug 18 2014;RNA;1;melanoma lymph node, fresh frozen tissue (>80% tumor cell content, <30% necrosis);Homo sapiens;patient age at primary diagnosis (years): 32;patient sex: Male;patient age at stage iii sample banked (years): 45;survival from stage iii tumour banked (months): 108.13;survival from primary melanoma (months): 260.88;patient last status: Alive NSR;number of primary melanomas: 2;stage at primary diagnosis 5th edition: Stage I;Tissue samples were homogenized using a high-speed agitation polytron blender (Kinematica, Luzern, Switzerland) in the presence of Trizol.;Total RNA was extracted from 20-30mg of fresh frozen tissue.;total RNA;The RNA was isolated and purified with an RNeasy purification kit (Qiagen RNeasy purification kit- Qiagen Pty Ltd., Clifton Hill, Victoria, Australia) with DNAse I digestion on the column. The quality of the RNA preparations was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA, USA). RNA integrity scores were >8 for all samples analyzed.;biotin;cRNA amplification and labelling with biotin were performed using Illumina TotalPrep RNA amplification kit according to the manufacturer’s directions (Ambion, Inc., Austin, TX, USA) with 250ng total RNA as input material.;9606;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Quality control was performed on all chips using R/Bioconductor and the lumi package (www.bioconductor.org). Data normalization was performed using a variance-stabilizing transform (VST) and quantile normalization as implemented in the lumi package for R/Bioconductor. To reduce false positives, unexpressed genes (detection p-value >0.01) were removed, reducing the number of probes analysed from 48,802 to 26,085.;GPL6884;Graham,J.,Mann;graham.mann@sydney.edu.au;Melanoma Institute Australia;Poche Centre, 40 Rocklands Road;North Sydney;NSW;2060;Australia;NONE;26085;Reanalysis of: GSM1282652;2;32;45;Alive NSR;Male;Stage I;260,88;108,13
0;0,006702194;0,036861684;0;0;0,546027156;0,410408966;GSM1315928;melanoma AJCCstageIII TumourID93;Public on Aug 18 2014;Jan 28 2014;Aug 18 2014;RNA;1;melanoma lymph node, fresh frozen tissue (>80% tumor cell content, <30% necrosis);Homo sapiens;patient age at primary diagnosis (years): 77;patient sex: Female;patient age at stage iii sample banked (years): 78;survival from stage iii tumour banked (months): 1.41;survival from primary melanoma (months): 19.66;patient last status: Dead Melanoma;number of primary melanomas: 1;stage at primary diagnosis 5th edition: Stage III;Tissue samples were homogenized using a high-speed agitation polytron blender (Kinematica, Luzern, Switzerland) in the presence of Trizol.;Total RNA was extracted from 20-30mg of fresh frozen tissue.;total RNA;The RNA was isolated and purified with an RNeasy purification kit (Qiagen RNeasy purification kit- Qiagen Pty Ltd., Clifton Hill, Victoria, Australia) with DNAse I digestion on the column. The quality of the RNA preparations was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA, USA). RNA integrity scores were >8 for all samples analyzed.;biotin;cRNA amplification and labelling with biotin were performed using Illumina TotalPrep RNA amplification kit according to the manufacturer’s directions (Ambion, Inc., Austin, TX, USA) with 250ng total RNA as input material.;9606;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Quality control was performed on all chips using R/Bioconductor and the lumi package (www.bioconductor.org). Data normalization was performed using a variance-stabilizing transform (VST) and quantile normalization as implemented in the lumi package for R/Bioconductor. To reduce false positives, unexpressed genes (detection p-value >0.01) were removed, reducing the number of probes analysed from 48,802 to 26,085.;GPL6884;Graham,J.,Mann;graham.mann@sydney.edu.au;Melanoma Institute Australia;Poche Centre, 40 Rocklands Road;North Sydney;NSW;2060;Australia;NONE;26085;Reanalysis of: GSM1282619;1;77;78;Dead Melanoma;Female;Stage III;19,66;1,41
0,058156328;0,002989321;0;0,141533727;0;0,327481299;0,469839325;GSM1315929;melanoma AJCCstageIII TumourID394;Public on Aug 18 2014;Jan 28 2014;Aug 18 2014;RNA;1;melanoma lymph node, fresh frozen tissue (>80% tumor cell content, <30% necrosis);Homo sapiens;patient age at primary diagnosis (years): 56;patient sex: Male;patient age at stage iii sample banked (years): 56;survival from stage iii tumour banked (months): 18.90;survival from primary melanoma (months): 19.63;patient last status: Dead Melanoma;number of primary melanomas: 1;stage at primary diagnosis 5th edition: Stage III;Tissue samples were homogenized using a high-speed agitation polytron blender (Kinematica, Luzern, Switzerland) in the presence of Trizol.;Total RNA was extracted from 20-30mg of fresh frozen tissue.;total RNA;The RNA was isolated and purified with an RNeasy purification kit (Qiagen RNeasy purification kit- Qiagen Pty Ltd., Clifton Hill, Victoria, Australia) with DNAse I digestion on the column. The quality of the RNA preparations was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA, USA). RNA integrity scores were >8 for all samples analyzed.;biotin;cRNA amplification and labelling with biotin were performed using Illumina TotalPrep RNA amplification kit according to the manufacturer’s directions (Ambion, Inc., Austin, TX, USA) with 250ng total RNA as input material.;9606;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Quality control was performed on all chips using R/Bioconductor and the lumi package (www.bioconductor.org). Data normalization was performed using a variance-stabilizing transform (VST) and quantile normalization as implemented in the lumi package for R/Bioconductor. To reduce false positives, unexpressed genes (detection p-value >0.01) were removed, reducing the number of probes analysed from 48,802 to 26,085.;GPL6884;Graham,J.,Mann;graham.mann@sydney.edu.au;Melanoma Institute Australia;Poche Centre, 40 Rocklands Road;North Sydney;NSW;2060;Australia;NONE;26085;Reanalysis of: GSM1282666;1;56;56;Dead Melanoma;Male;Stage III;19,63;18,9
0,08870196;0,029206708;0,07574328;0,08094845;0,101484876;0;0,623914726;GSM1315930;melanoma AJCCstageIII TumourID102;Public on Aug 18 2014;Jan 28 2014;Aug 18 2014;RNA;1;melanoma lymph node, fresh frozen tissue (>80% tumor cell content, <30% necrosis);Homo sapiens;patient age at primary diagnosis (years): 39;patient sex: Female;patient age at stage iii sample banked (years): 40;survival from stage iii tumour banked (months): 7.43;survival from primary melanoma (months): 21.47;patient last status: Dead Melanoma;number of primary melanomas: 1;stage at primary diagnosis 5th edition: Stage II;Tissue samples were homogenized using a high-speed agitation polytron blender (Kinematica, Luzern, Switzerland) in the presence of Trizol.;Total RNA was extracted from 20-30mg of fresh frozen tissue.;total RNA;The RNA was isolated and purified with an RNeasy purification kit (Qiagen RNeasy purification kit- Qiagen Pty Ltd., Clifton Hill, Victoria, Australia) with DNAse I digestion on the column. The quality of the RNA preparations was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA, USA). RNA integrity scores were >8 for all samples analyzed.;biotin;cRNA amplification and labelling with biotin were performed using Illumina TotalPrep RNA amplification kit according to the manufacturer’s directions (Ambion, Inc., Austin, TX, USA) with 250ng total RNA as input material.;9606;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Quality control was performed on all chips using R/Bioconductor and the lumi package (www.bioconductor.org). Data normalization was performed using a variance-stabilizing transform (VST) and quantile normalization as implemented in the lumi package for R/Bioconductor. To reduce false positives, unexpressed genes (detection p-value >0.01) were removed, reducing the number of probes analysed from 48,802 to 26,085.;GPL6884;Graham,J.,Mann;graham.mann@sydney.edu.au;Melanoma Institute Australia;Poche Centre, 40 Rocklands Road;North Sydney;NSW;2060;Australia;NONE;26085;Reanalysis of: GSM1282622;1;39;40;Dead Melanoma;Female;Stage II;21,47;7,43
0,155666028;0,003482331;0,043663162;0,166172561;0,079359468;0;0,55165645;GSM1315931;melanoma AJCCstageIII TumourID94;Public on Aug 18 2014;Jan 28 2014;Aug 18 2014;RNA;1;melanoma lymph node, fresh frozen tissue (>80% tumor cell content, <30% necrosis);Homo sapiens;patient age at primary diagnosis (years): 84;patient sex: Female;patient age at stage iii sample banked (years): 87;survival from stage iii tumour banked (months): 75.39;survival from primary melanoma (months): 103.00;patient last status: Dead Cause Unknown;number of primary melanomas: 3;stage at primary diagnosis 5th edition: Stage II;Tissue samples were homogenized using a high-speed agitation polytron blender (Kinematica, Luzern, Switzerland) in the presence of Trizol.;Total RNA was extracted from 20-30mg of fresh frozen tissue.;total RNA;The RNA was isolated and purified with an RNeasy purification kit (Qiagen RNeasy purification kit- Qiagen Pty Ltd., Clifton Hill, Victoria, Australia) with DNAse I digestion on the column. The quality of the RNA preparations was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA, USA). RNA integrity scores were >8 for all samples analyzed.;biotin;cRNA amplification and labelling with biotin were performed using Illumina TotalPrep RNA amplification kit according to the manufacturer’s directions (Ambion, Inc., Austin, TX, USA) with 250ng total RNA as input material.;9606;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Quality control was performed on all chips using R/Bioconductor and the lumi package (www.bioconductor.org). Data normalization was performed using a variance-stabilizing transform (VST) and quantile normalization as implemented in the lumi package for R/Bioconductor. To reduce false positives, unexpressed genes (detection p-value >0.01) were removed, reducing the number of probes analysed from 48,802 to 26,085.;GPL6884;Graham,J.,Mann;graham.mann@sydney.edu.au;Melanoma Institute Australia;Poche Centre, 40 Rocklands Road;North Sydney;NSW;2060;Australia;NONE;26085;Reanalysis of: GSM1282620;3;84;87;Dead Cause Unknown;Female;Stage II;103;75,39
0,070270488;0,016514384;0,037396414;0;0;0,393274951;0,482543763;GSM1315932;melanoma AJCCstageIII TumourID237;Public on Aug 18 2014;Jan 28 2014;Aug 18 2014;RNA;1;melanoma lymph node, fresh frozen tissue (>80% tumor cell content, <30% necrosis);Homo sapiens;patient age at primary diagnosis (years): 57;patient sex: Female;patient age at stage iii sample banked (years): 60;survival from stage iii tumour banked (months): 11.90;survival from primary melanoma (months): 57.83;patient last status: Dead Melanoma;number of primary melanomas: 1;stage at primary diagnosis 5th edition: Stage II;Tissue samples were homogenized using a high-speed agitation polytron blender (Kinematica, Luzern, Switzerland) in the presence of Trizol.;Total RNA was extracted from 20-30mg of fresh frozen tissue.;total RNA;The RNA was isolated and purified with an RNeasy purification kit (Qiagen RNeasy purification kit- Qiagen Pty Ltd., Clifton Hill, Victoria, Australia) with DNAse I digestion on the column. The quality of the RNA preparations was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA, USA). RNA integrity scores were >8 for all samples analyzed.;biotin;cRNA amplification and labelling with biotin were performed using Illumina TotalPrep RNA amplification kit according to the manufacturer’s directions (Ambion, Inc., Austin, TX, USA) with 250ng total RNA as input material.;9606;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Quality control was performed on all chips using R/Bioconductor and the lumi package (www.bioconductor.org). Data normalization was performed using a variance-stabilizing transform (VST) and quantile normalization as implemented in the lumi package for R/Bioconductor. To reduce false positives, unexpressed genes (detection p-value >0.01) were removed, reducing the number of probes analysed from 48,802 to 26,085.;GPL6884;Graham,J.,Mann;graham.mann@sydney.edu.au;Melanoma Institute Australia;Poche Centre, 40 Rocklands Road;North Sydney;NSW;2060;Australia;NONE;26085;Reanalysis of: GSM1282645;1;57;60;Dead Melanoma;Female;Stage II;57,83;11,9
0,216453284;0,009983972;0,016249463;0,139347071;0,016336434;0;0,601629775;GSM1315933;melanoma AJCCstageIII TumourID139;Public on Aug 18 2014;Jan 28 2014;Aug 18 2014;RNA;1;melanoma lymph node, fresh frozen tissue (>80% tumor cell content, <30% necrosis);Homo sapiens;patient age at primary diagnosis (years): 23;patient sex: Male;patient age at stage iii sample banked (years): 28;survival from stage iii tumour banked (months): 43.59;survival from primary melanoma (months): 103.20;patient last status: Dead Melanoma;number of primary melanomas: 1;stage at primary diagnosis 5th edition: Stage I;Tissue samples were homogenized using a high-speed agitation polytron blender (Kinematica, Luzern, Switzerland) in the presence of Trizol.;Total RNA was extracted from 20-30mg of fresh frozen tissue.;total RNA;The RNA was isolated and purified with an RNeasy purification kit (Qiagen RNeasy purification kit- Qiagen Pty Ltd., Clifton Hill, Victoria, Australia) with DNAse I digestion on the column. The quality of the RNA preparations was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA, USA). RNA integrity scores were >8 for all samples analyzed.;biotin;cRNA amplification and labelling with biotin were performed using Illumina TotalPrep RNA amplification kit according to the manufacturer’s directions (Ambion, Inc., Austin, TX, USA) with 250ng total RNA as input material.;9606;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Quality control was performed on all chips using R/Bioconductor and the lumi package (www.bioconductor.org). Data normalization was performed using a variance-stabilizing transform (VST) and quantile normalization as implemented in the lumi package for R/Bioconductor. To reduce false positives, unexpressed genes (detection p-value >0.01) were removed, reducing the number of probes analysed from 48,802 to 26,085.;GPL6884;Graham,J.,Mann;graham.mann@sydney.edu.au;Melanoma Institute Australia;Poche Centre, 40 Rocklands Road;North Sydney;NSW;2060;Australia;NONE;26085;Reanalysis of: GSM1282628;1;23;28;Dead Melanoma;Male;Stage I;103,2;43,59
0,221634409;0,000980531;0;0;0;0,175037988;0,602347072;GSM1315934;melanoma AJCCstageIII TumourID273;Public on Aug 18 2014;Jan 28 2014;Aug 18 2014;RNA;1;melanoma lymph node, fresh frozen tissue (>80% tumor cell content, <30% necrosis);Homo sapiens;patient age at primary diagnosis (years): 63;patient sex: Male;patient age at stage iii sample banked (years): 66;survival from stage iii tumour banked (months): 62.89;survival from primary melanoma (months): 100.24;patient last status: Dead Melanoma;number of primary melanomas: 1;stage at primary diagnosis 5th edition: Stage I;Tissue samples were homogenized using a high-speed agitation polytron blender (Kinematica, Luzern, Switzerland) in the presence of Trizol.;Total RNA was extracted from 20-30mg of fresh frozen tissue.;total RNA;The RNA was isolated and purified with an RNeasy purification kit (Qiagen RNeasy purification kit- Qiagen Pty Ltd., Clifton Hill, Victoria, Australia) with DNAse I digestion on the column. The quality of the RNA preparations was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA, USA). RNA integrity scores were >8 for all samples analyzed.;biotin;cRNA amplification and labelling with biotin were performed using Illumina TotalPrep RNA amplification kit according to the manufacturer’s directions (Ambion, Inc., Austin, TX, USA) with 250ng total RNA as input material.;9606;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Quality control was performed on all chips using R/Bioconductor and the lumi package (www.bioconductor.org). Data normalization was performed using a variance-stabilizing transform (VST) and quantile normalization as implemented in the lumi package for R/Bioconductor. To reduce false positives, unexpressed genes (detection p-value >0.01) were removed, reducing the number of probes analysed from 48,802 to 26,085.;GPL6884;Graham,J.,Mann;graham.mann@sydney.edu.au;Melanoma Institute Australia;Poche Centre, 40 Rocklands Road;North Sydney;NSW;2060;Australia;NONE;26085;Reanalysis of: GSM1282649;1;63;66;Dead Melanoma;Male;Stage I;100,24;62,89
0,087032989;0,117073568;0,041538079;0;0;0,216067202;0,538288162;GSM1315935;melanoma AJCCstageIII TumourID322;Public on Aug 18 2014;Jan 28 2014;Aug 18 2014;RNA;1;melanoma lymph node, fresh frozen tissue (>80% tumor cell content, <30% necrosis);Homo sapiens;patient age at primary diagnosis (years): 53;patient sex: Male;patient age at stage iii sample banked (years): 54;survival from stage iii tumour banked (months): 6.21;survival from primary melanoma (months): 24.13;patient last status: Dead Melanoma;number of primary melanomas: 1;stage at primary diagnosis 5th edition: Stage II;Tissue samples were homogenized using a high-speed agitation polytron blender (Kinematica, Luzern, Switzerland) in the presence of Trizol.;Total RNA was extracted from 20-30mg of fresh frozen tissue.;total RNA;The RNA was isolated and purified with an RNeasy purification kit (Qiagen RNeasy purification kit- Qiagen Pty Ltd., Clifton Hill, Victoria, Australia) with DNAse I digestion on the column. The quality of the RNA preparations was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA, USA). RNA integrity scores were >8 for all samples analyzed.;biotin;cRNA amplification and labelling with biotin were performed using Illumina TotalPrep RNA amplification kit according to the manufacturer’s directions (Ambion, Inc., Austin, TX, USA) with 250ng total RNA as input material.;9606;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Quality control was performed on all chips using R/Bioconductor and the lumi package (www.bioconductor.org). Data normalization was performed using a variance-stabilizing transform (VST) and quantile normalization as implemented in the lumi package for R/Bioconductor. To reduce false positives, unexpressed genes (detection p-value >0.01) were removed, reducing the number of probes analysed from 48,802 to 26,085.;GPL6884;Graham,J.,Mann;graham.mann@sydney.edu.au;Melanoma Institute Australia;Poche Centre, 40 Rocklands Road;North Sydney;NSW;2060;Australia;NONE;26085;Reanalysis of: GSM1282653;1;53;54;Dead Melanoma;Male;Stage II;24,13;6,21
0,151867043;0,014287563;0,024482139;0;0;0,272280243;0,537083012;GSM1315936;melanoma AJCCstageIII TumourID350;Public on Aug 18 2014;Jan 28 2014;Aug 18 2014;RNA;1;melanoma lymph node, fresh frozen tissue (>80% tumor cell content, <30% necrosis);Homo sapiens;patient age at primary diagnosis (years): 72;patient sex: Male;patient age at stage iii sample banked (years): 72;survival from stage iii tumour banked (months): 96.92;survival from primary melanoma (months): 106.85;patient last status: Alive NSR;number of primary melanomas: 2;stage at primary diagnosis 5th edition: Stage II;Tissue samples were homogenized using a high-speed agitation polytron blender (Kinematica, Luzern, Switzerland) in the presence of Trizol.;Total RNA was extracted from 20-30mg of fresh frozen tissue.;total RNA;The RNA was isolated and purified with an RNeasy purification kit (Qiagen RNeasy purification kit- Qiagen Pty Ltd., Clifton Hill, Victoria, Australia) with DNAse I digestion on the column. The quality of the RNA preparations was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA, USA). RNA integrity scores were >8 for all samples analyzed.;biotin;cRNA amplification and labelling with biotin were performed using Illumina TotalPrep RNA amplification kit according to the manufacturer’s directions (Ambion, Inc., Austin, TX, USA) with 250ng total RNA as input material.;9606;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Quality control was performed on all chips using R/Bioconductor and the lumi package (www.bioconductor.org). Data normalization was performed using a variance-stabilizing transform (VST) and quantile normalization as implemented in the lumi package for R/Bioconductor. To reduce false positives, unexpressed genes (detection p-value >0.01) were removed, reducing the number of probes analysed from 48,802 to 26,085.;GPL6884;Graham,J.,Mann;graham.mann@sydney.edu.au;Melanoma Institute Australia;Poche Centre, 40 Rocklands Road;North Sydney;NSW;2060;Australia;NONE;26085;Reanalysis of: GSM1282659;2;72;72;Alive NSR;Male;Stage II;106,85;96,92
0;0,080808526;0,061796366;0;0;0,412969147;0,444425961;GSM1315937;melanoma AJCCstageIII TumourID196;Public on Aug 18 2014;Jan 28 2014;Aug 18 2014;RNA;1;melanoma lymph node, fresh frozen tissue (>80% tumor cell content, <30% necrosis);Homo sapiens;patient age at primary diagnosis (years): 60;patient sex: Male;patient age at stage iii sample banked (years): 67;survival from stage iii tumour banked (months): 21.63;survival from primary melanoma (months): 107.61;patient last status: Dead Melanoma;number of primary melanomas: 2;stage at primary diagnosis 5th edition: Stage I;Tissue samples were homogenized using a high-speed agitation polytron blender (Kinematica, Luzern, Switzerland) in the presence of Trizol.;Total RNA was extracted from 20-30mg of fresh frozen tissue.;total RNA;The RNA was isolated and purified with an RNeasy purification kit (Qiagen RNeasy purification kit- Qiagen Pty Ltd., Clifton Hill, Victoria, Australia) with DNAse I digestion on the column. The quality of the RNA preparations was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA, USA). RNA integrity scores were >8 for all samples analyzed.;biotin;cRNA amplification and labelling with biotin were performed using Illumina TotalPrep RNA amplification kit according to the manufacturer’s directions (Ambion, Inc., Austin, TX, USA) with 250ng total RNA as input material.;9606;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Quality control was performed on all chips using R/Bioconductor and the lumi package (www.bioconductor.org). Data normalization was performed using a variance-stabilizing transform (VST) and quantile normalization as implemented in the lumi package for R/Bioconductor. To reduce false positives, unexpressed genes (detection p-value >0.01) were removed, reducing the number of probes analysed from 48,802 to 26,085.;GPL6884;Graham,J.,Mann;graham.mann@sydney.edu.au;Melanoma Institute Australia;Poche Centre, 40 Rocklands Road;North Sydney;NSW;2060;Australia;NONE;26085;Reanalysis of: GSM1282636;2;60;67;Dead Melanoma;Male;Stage I;107,61;21,63
0,217934699;0,064679769;0,085104023;0;0;0,031411473;0,600870037;GSM1315938;melanoma AJCCstageIII TumourID47;Public on Aug 18 2014;Jan 28 2014;Aug 18 2014;RNA;1;melanoma lymph node, fresh frozen tissue (>80% tumor cell content, <30% necrosis);Homo sapiens;patient age at primary diagnosis (years): 67;patient sex: Male;patient age at stage iii sample banked (years): 69;survival from stage iii tumour banked (months): 2.30;survival from primary melanoma (months): 28.83;patient last status: Dead Melanoma;number of primary melanomas: 1;stage at primary diagnosis 5th edition: Stage II;Tissue samples were homogenized using a high-speed agitation polytron blender (Kinematica, Luzern, Switzerland) in the presence of Trizol.;Total RNA was extracted from 20-30mg of fresh frozen tissue.;total RNA;The RNA was isolated and purified with an RNeasy purification kit (Qiagen RNeasy purification kit- Qiagen Pty Ltd., Clifton Hill, Victoria, Australia) with DNAse I digestion on the column. The quality of the RNA preparations was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA, USA). RNA integrity scores were >8 for all samples analyzed.;biotin;cRNA amplification and labelling with biotin were performed using Illumina TotalPrep RNA amplification kit according to the manufacturer’s directions (Ambion, Inc., Austin, TX, USA) with 250ng total RNA as input material.;9606;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Quality control was performed on all chips using R/Bioconductor and the lumi package (www.bioconductor.org). Data normalization was performed using a variance-stabilizing transform (VST) and quantile normalization as implemented in the lumi package for R/Bioconductor. To reduce false positives, unexpressed genes (detection p-value >0.01) were removed, reducing the number of probes analysed from 48,802 to 26,085.;GPL6884;Graham,J.,Mann;graham.mann@sydney.edu.au;Melanoma Institute Australia;Poche Centre, 40 Rocklands Road;North Sydney;NSW;2060;Australia;NONE;26085;Reanalysis of: GSM1282605;1;67;69;Dead Melanoma;Male;Stage II;28,83;2,3
0,063149461;0;0;0;0;0,466196282;0,470654258;GSM1315939;melanoma AJCCstageIII TumourID13;Public on Aug 18 2014;Jan 28 2014;Aug 18 2014;RNA;1;melanoma lymph node, fresh frozen tissue (>80% tumor cell content, <30% necrosis);Homo sapiens;patient age at primary diagnosis (years): 61;patient sex: Male;patient age at stage iii sample banked (years): 61;survival from stage iii tumour banked (months): 9.73;survival from primary melanoma (months): 10.85;patient last status: Dead Melanoma;number of primary melanomas: 1;stage at primary diagnosis 5th edition: Stage III;Tissue samples were homogenized using a high-speed agitation polytron blender (Kinematica, Luzern, Switzerland) in the presence of Trizol.;Total RNA was extracted from 20-30mg of fresh frozen tissue.;total RNA;The RNA was isolated and purified with an RNeasy purification kit (Qiagen RNeasy purification kit- Qiagen Pty Ltd., Clifton Hill, Victoria, Australia) with DNAse I digestion on the column. The quality of the RNA preparations was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA, USA). RNA integrity scores were >8 for all samples analyzed.;biotin;cRNA amplification and labelling with biotin were performed using Illumina TotalPrep RNA amplification kit according to the manufacturer’s directions (Ambion, Inc., Austin, TX, USA) with 250ng total RNA as input material.;9606;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Quality control was performed on all chips using R/Bioconductor and the lumi package (www.bioconductor.org). Data normalization was performed using a variance-stabilizing transform (VST) and quantile normalization as implemented in the lumi package for R/Bioconductor. To reduce false positives, unexpressed genes (detection p-value >0.01) were removed, reducing the number of probes analysed from 48,802 to 26,085.;GPL6884;Graham,J.,Mann;graham.mann@sydney.edu.au;Melanoma Institute Australia;Poche Centre, 40 Rocklands Road;North Sydney;NSW;2060;Australia;NONE;26085;Reanalysis of: GSM1282592;1;61;61;Dead Melanoma;Male;Stage III;10,85;9,73
0,288534654;0;0;0,038426834;0,045971968;0;0,627066544;GSM1315940;melanoma AJCCstageIII TumourID333;Public on Aug 18 2014;Jan 28 2014;Aug 18 2014;RNA;1;melanoma lymph node, fresh frozen tissue (>80% tumor cell content, <30% necrosis);Homo sapiens;patient age at primary diagnosis (years): 35;patient sex: Male;patient age at stage iii sample banked (years): 54;survival from stage iii tumour banked (months): 51.62;survival from primary melanoma (months): 284.22;patient last status: Alive NSR;number of primary melanomas: 1;stage at primary diagnosis 5th edition: Stage II;Tissue samples were homogenized using a high-speed agitation polytron blender (Kinematica, Luzern, Switzerland) in the presence of Trizol.;Total RNA was extracted from 20-30mg of fresh frozen tissue.;total RNA;The RNA was isolated and purified with an RNeasy purification kit (Qiagen RNeasy purification kit- Qiagen Pty Ltd., Clifton Hill, Victoria, Australia) with DNAse I digestion on the column. The quality of the RNA preparations was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA, USA). RNA integrity scores were >8 for all samples analyzed.;biotin;cRNA amplification and labelling with biotin were performed using Illumina TotalPrep RNA amplification kit according to the manufacturer’s directions (Ambion, Inc., Austin, TX, USA) with 250ng total RNA as input material.;9606;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Quality control was performed on all chips using R/Bioconductor and the lumi package (www.bioconductor.org). Data normalization was performed using a variance-stabilizing transform (VST) and quantile normalization as implemented in the lumi package for R/Bioconductor. To reduce false positives, unexpressed genes (detection p-value >0.01) were removed, reducing the number of probes analysed from 48,802 to 26,085.;GPL6884;Graham,J.,Mann;graham.mann@sydney.edu.au;Melanoma Institute Australia;Poche Centre, 40 Rocklands Road;North Sydney;NSW;2060;Australia;NONE;26085;Reanalysis of: GSM1282654;1;35;54;Alive NSR;Male;Stage II;284,22;51,62
0,278584385;0;0;0,00691155;0;0;0,714504065;GSM1315941;melanoma AJCCstageIII TumourID152;Public on Aug 18 2014;Jan 28 2014;Aug 18 2014;RNA;1;melanoma lymph node, fresh frozen tissue (>80% tumor cell content, <30% necrosis);Homo sapiens;patient age at primary diagnosis (years): 60;patient sex: Male;patient age at stage iii sample banked (years): 63;survival from stage iii tumour banked (months): 63.42;survival from primary melanoma (months): 96.23;patient last status: Dead Not Melanoma;number of primary melanomas: 1;stage at primary diagnosis 5th edition: Stage II;Tissue samples were homogenized using a high-speed agitation polytron blender (Kinematica, Luzern, Switzerland) in the presence of Trizol.;Total RNA was extracted from 20-30mg of fresh frozen tissue.;total RNA;The RNA was isolated and purified with an RNeasy purification kit (Qiagen RNeasy purification kit- Qiagen Pty Ltd., Clifton Hill, Victoria, Australia) with DNAse I digestion on the column. The quality of the RNA preparations was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA, USA). RNA integrity scores were >8 for all samples analyzed.;biotin;cRNA amplification and labelling with biotin were performed using Illumina TotalPrep RNA amplification kit according to the manufacturer’s directions (Ambion, Inc., Austin, TX, USA) with 250ng total RNA as input material.;9606;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Quality control was performed on all chips using R/Bioconductor and the lumi package (www.bioconductor.org). Data normalization was performed using a variance-stabilizing transform (VST) and quantile normalization as implemented in the lumi package for R/Bioconductor. To reduce false positives, unexpressed genes (detection p-value >0.01) were removed, reducing the number of probes analysed from 48,802 to 26,085.;GPL6884;Graham,J.,Mann;graham.mann@sydney.edu.au;Melanoma Institute Australia;Poche Centre, 40 Rocklands Road;North Sydney;NSW;2060;Australia;NONE;26085;Reanalysis of: GSM1282631;1;60;63;Dead Not Melanoma;Male;Stage II;96,23;63,42
0,077457466;0,055197754;0;0,066511522;0;0,299644747;0,501188511;GSM1315942;melanoma AJCCstageIII TumourID69;Public on Aug 18 2014;Jan 28 2014;Aug 18 2014;RNA;1;melanoma lymph node, fresh frozen tissue (>80% tumor cell content, <30% necrosis);Homo sapiens;patient age at primary diagnosis (years): 30;patient sex: Male;patient age at stage iii sample banked (years): 30;survival from stage iii tumour banked (months): 69.53;survival from primary melanoma (months): 70.49;patient last status: Alive NSR;number of primary melanomas: 1;stage at primary diagnosis 5th edition: Stage III;Tissue samples were homogenized using a high-speed agitation polytron blender (Kinematica, Luzern, Switzerland) in the presence of Trizol.;Total RNA was extracted from 20-30mg of fresh frozen tissue.;total RNA;The RNA was isolated and purified with an RNeasy purification kit (Qiagen RNeasy purification kit- Qiagen Pty Ltd., Clifton Hill, Victoria, Australia) with DNAse I digestion on the column. The quality of the RNA preparations was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA, USA). RNA integrity scores were >8 for all samples analyzed.;biotin;cRNA amplification and labelling with biotin were performed using Illumina TotalPrep RNA amplification kit according to the manufacturer’s directions (Ambion, Inc., Austin, TX, USA) with 250ng total RNA as input material.;9606;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Quality control was performed on all chips using R/Bioconductor and the lumi package (www.bioconductor.org). Data normalization was performed using a variance-stabilizing transform (VST) and quantile normalization as implemented in the lumi package for R/Bioconductor. To reduce false positives, unexpressed genes (detection p-value >0.01) were removed, reducing the number of probes analysed from 48,802 to 26,085.;GPL6884;Graham,J.,Mann;graham.mann@sydney.edu.au;Melanoma Institute Australia;Poche Centre, 40 Rocklands Road;North Sydney;NSW;2060;Australia;NONE;26085;Reanalysis of: GSM1282615;1;30;30;Alive NSR;Male;Stage III;70,49;69,53
0,354830946;0;0;0;0,000840989;0;0,644328065;GSM1315943;melanoma AJCCstageIII TumourID142;Public on Aug 18 2014;Jan 28 2014;Aug 18 2014;RNA;1;melanoma lymph node, fresh frozen tissue (>80% tumor cell content, <30% necrosis);Homo sapiens;patient age at primary diagnosis (years): 66;patient sex: Male;patient age at stage iii sample banked (years): 67;survival from stage iii tumour banked (months): 7.07;survival from primary melanoma (months): 16.96;patient last status: Dead Melanoma;number of primary melanomas: 1;stage at primary diagnosis 5th edition: Stage II;Tissue samples were homogenized using a high-speed agitation polytron blender (Kinematica, Luzern, Switzerland) in the presence of Trizol.;Total RNA was extracted from 20-30mg of fresh frozen tissue.;total RNA;The RNA was isolated and purified with an RNeasy purification kit (Qiagen RNeasy purification kit- Qiagen Pty Ltd., Clifton Hill, Victoria, Australia) with DNAse I digestion on the column. The quality of the RNA preparations was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA, USA). RNA integrity scores were >8 for all samples analyzed.;biotin;cRNA amplification and labelling with biotin were performed using Illumina TotalPrep RNA amplification kit according to the manufacturer’s directions (Ambion, Inc., Austin, TX, USA) with 250ng total RNA as input material.;9606;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Quality control was performed on all chips using R/Bioconductor and the lumi package (www.bioconductor.org). Data normalization was performed using a variance-stabilizing transform (VST) and quantile normalization as implemented in the lumi package for R/Bioconductor. To reduce false positives, unexpressed genes (detection p-value >0.01) were removed, reducing the number of probes analysed from 48,802 to 26,085.;GPL6884;Graham,J.,Mann;graham.mann@sydney.edu.au;Melanoma Institute Australia;Poche Centre, 40 Rocklands Road;North Sydney;NSW;2060;Australia;NONE;26085;Reanalysis of: GSM1282629;1;66;67;Dead Melanoma;Male;Stage II;16,96;7,07
0,189130455;0;0;0,136235388;0,040983266;0;0,633650891;GSM1315944;melanoma AJCCstageIII TumourID387;Public on Aug 18 2014;Jan 28 2014;Aug 18 2014;RNA;1;melanoma lymph node, fresh frozen tissue (>80% tumor cell content, <30% necrosis);Homo sapiens;patient age at primary diagnosis (years): 50;patient sex: Female;patient age at stage iii sample banked (years): 54;survival from stage iii tumour banked (months): 22.06;survival from primary melanoma (months): 68.75;patient last status: Dead Melanoma;number of primary melanomas: 1;stage at primary diagnosis 5th edition: Stage II;Tissue samples were homogenized using a high-speed agitation polytron blender (Kinematica, Luzern, Switzerland) in the presence of Trizol.;Total RNA was extracted from 20-30mg of fresh frozen tissue.;total RNA;The RNA was isolated and purified with an RNeasy purification kit (Qiagen RNeasy purification kit- Qiagen Pty Ltd., Clifton Hill, Victoria, Australia) with DNAse I digestion on the column. The quality of the RNA preparations was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA, USA). RNA integrity scores were >8 for all samples analyzed.;biotin;cRNA amplification and labelling with biotin were performed using Illumina TotalPrep RNA amplification kit according to the manufacturer’s directions (Ambion, Inc., Austin, TX, USA) with 250ng total RNA as input material.;9606;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Quality control was performed on all chips using R/Bioconductor and the lumi package (www.bioconductor.org). Data normalization was performed using a variance-stabilizing transform (VST) and quantile normalization as implemented in the lumi package for R/Bioconductor. To reduce false positives, unexpressed genes (detection p-value >0.01) were removed, reducing the number of probes analysed from 48,802 to 26,085.;GPL6884;Graham,J.,Mann;graham.mann@sydney.edu.au;Melanoma Institute Australia;Poche Centre, 40 Rocklands Road;North Sydney;NSW;2060;Australia;NONE;26085;Reanalysis of: GSM1282665;1;50;54;Dead Melanoma;Female;Stage II;68,75;22,06
0,05791349;0,022014148;0;0,099428944;0,002624263;0,304575729;0,513443426;GSM1315945;melanoma AJCCstageIII TumourID53;Public on Aug 18 2014;Jan 28 2014;Aug 18 2014;RNA;1;melanoma lymph node, fresh frozen tissue (>80% tumor cell content, <30% necrosis);Homo sapiens;patient age at primary diagnosis (years): 28;patient sex: Male;patient age at stage iii sample banked (years): 30;survival from stage iii tumour banked (months): 79.17;survival from primary melanoma (months): 103.13;patient last status: Dead Melanoma;number of primary melanomas: 1;stage at primary diagnosis 5th edition: Stage II;Tissue samples were homogenized using a high-speed agitation polytron blender (Kinematica, Luzern, Switzerland) in the presence of Trizol.;Total RNA was extracted from 20-30mg of fresh frozen tissue.;total RNA;The RNA was isolated and purified with an RNeasy purification kit (Qiagen RNeasy purification kit- Qiagen Pty Ltd., Clifton Hill, Victoria, Australia) with DNAse I digestion on the column. The quality of the RNA preparations was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA, USA). RNA integrity scores were >8 for all samples analyzed.;biotin;cRNA amplification and labelling with biotin were performed using Illumina TotalPrep RNA amplification kit according to the manufacturer’s directions (Ambion, Inc., Austin, TX, USA) with 250ng total RNA as input material.;9606;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Quality control was performed on all chips using R/Bioconductor and the lumi package (www.bioconductor.org). Data normalization was performed using a variance-stabilizing transform (VST) and quantile normalization as implemented in the lumi package for R/Bioconductor. To reduce false positives, unexpressed genes (detection p-value >0.01) were removed, reducing the number of probes analysed from 48,802 to 26,085.;GPL6884;Graham,J.,Mann;graham.mann@sydney.edu.au;Melanoma Institute Australia;Poche Centre, 40 Rocklands Road;North Sydney;NSW;2060;Australia;NONE;26085;Reanalysis of: GSM1282609;1;28;30;Dead Melanoma;Male;Stage II;103,13;79,17
0,267070305;0;0;0,001066887;0;0;0,731862807;GSM1315946;melanoma AJCCstageIII TumourID233;Public on Aug 18 2014;Jan 28 2014;Aug 18 2014;RNA;1;melanoma lymph node, fresh frozen tissue (>80% tumor cell content, <30% necrosis);Homo sapiens;patient age at primary diagnosis (years): 58;patient sex: Male;patient age at stage iii sample banked (years): 60;survival from stage iii tumour banked (months): 24.72;survival from primary melanoma (months): 47.54;patient last status: Dead Melanoma;number of primary melanomas: 1;stage at primary diagnosis 5th edition: Stage I;Tissue samples were homogenized using a high-speed agitation polytron blender (Kinematica, Luzern, Switzerland) in the presence of Trizol.;Total RNA was extracted from 20-30mg of fresh frozen tissue.;total RNA;The RNA was isolated and purified with an RNeasy purification kit (Qiagen RNeasy purification kit- Qiagen Pty Ltd., Clifton Hill, Victoria, Australia) with DNAse I digestion on the column. The quality of the RNA preparations was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA, USA). RNA integrity scores were >8 for all samples analyzed.;biotin;cRNA amplification and labelling with biotin were performed using Illumina TotalPrep RNA amplification kit according to the manufacturer’s directions (Ambion, Inc., Austin, TX, USA) with 250ng total RNA as input material.;9606;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Quality control was performed on all chips using R/Bioconductor and the lumi package (www.bioconductor.org). Data normalization was performed using a variance-stabilizing transform (VST) and quantile normalization as implemented in the lumi package for R/Bioconductor. To reduce false positives, unexpressed genes (detection p-value >0.01) were removed, reducing the number of probes analysed from 48,802 to 26,085.;GPL6884;Graham,J.,Mann;graham.mann@sydney.edu.au;Melanoma Institute Australia;Poche Centre, 40 Rocklands Road;North Sydney;NSW;2060;Australia;NONE;26085;Reanalysis of: GSM1282643;1;58;60;Dead Melanoma;Male;Stage I;47,54;24,72
0,056129244;0,035150926;0,046465735;0,057848923;0,020542764;0,211847998;0,572014412;GSM1315947;melanoma AJCCstageIII TumourID36;Public on Aug 18 2014;Jan 28 2014;Aug 18 2014;RNA;1;melanoma lymph node, fresh frozen tissue (>80% tumor cell content, <30% necrosis);Homo sapiens;patient age at primary diagnosis (years): 66;patient sex: Female;patient age at stage iii sample banked (years): 69;survival from stage iii tumour banked (months): 7.82;survival from primary melanoma (months): 50.63;patient last status: Dead Melanoma;number of primary melanomas: 1;stage at primary diagnosis 5th edition: Stage III;Tissue samples were homogenized using a high-speed agitation polytron blender (Kinematica, Luzern, Switzerland) in the presence of Trizol.;Total RNA was extracted from 20-30mg of fresh frozen tissue.;total RNA;The RNA was isolated and purified with an RNeasy purification kit (Qiagen RNeasy purification kit- Qiagen Pty Ltd., Clifton Hill, Victoria, Australia) with DNAse I digestion on the column. The quality of the RNA preparations was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA, USA). RNA integrity scores were >8 for all samples analyzed.;biotin;cRNA amplification and labelling with biotin were performed using Illumina TotalPrep RNA amplification kit according to the manufacturer’s directions (Ambion, Inc., Austin, TX, USA) with 250ng total RNA as input material.;9606;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Quality control was performed on all chips using R/Bioconductor and the lumi package (www.bioconductor.org). Data normalization was performed using a variance-stabilizing transform (VST) and quantile normalization as implemented in the lumi package for R/Bioconductor. To reduce false positives, unexpressed genes (detection p-value >0.01) were removed, reducing the number of probes analysed from 48,802 to 26,085.;GPL6884;Graham,J.,Mann;graham.mann@sydney.edu.au;Melanoma Institute Australia;Poche Centre, 40 Rocklands Road;North Sydney;NSW;2060;Australia;NONE;26085;Reanalysis of: GSM1282601;1;66;69;Dead Melanoma;Female;Stage III;50,63;7,82
0,037892833;0,035218302;0,029064536;0;0;0,453433399;0,444390929;GSM1315948;melanoma AJCCstageIII TumourID249;Public on Aug 18 2014;Jan 28 2014;Aug 18 2014;RNA;1;melanoma lymph node, fresh frozen tissue (>80% tumor cell content, <30% necrosis);Homo sapiens;patient age at primary diagnosis (years): 49;patient sex: Female;patient age at stage iii sample banked (years): 57;survival from stage iii tumour banked (months): 115.36;survival from primary melanoma (months): 219.42;patient last status: Alive NSR;number of primary melanomas: 2;stage at primary diagnosis 5th edition: Stage I;Tissue samples were homogenized using a high-speed agitation polytron blender (Kinematica, Luzern, Switzerland) in the presence of Trizol.;Total RNA was extracted from 20-30mg of fresh frozen tissue.;total RNA;The RNA was isolated and purified with an RNeasy purification kit (Qiagen RNeasy purification kit- Qiagen Pty Ltd., Clifton Hill, Victoria, Australia) with DNAse I digestion on the column. The quality of the RNA preparations was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA, USA). RNA integrity scores were >8 for all samples analyzed.;biotin;cRNA amplification and labelling with biotin were performed using Illumina TotalPrep RNA amplification kit according to the manufacturer’s directions (Ambion, Inc., Austin, TX, USA) with 250ng total RNA as input material.;9606;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Quality control was performed on all chips using R/Bioconductor and the lumi package (www.bioconductor.org). Data normalization was performed using a variance-stabilizing transform (VST) and quantile normalization as implemented in the lumi package for R/Bioconductor. To reduce false positives, unexpressed genes (detection p-value >0.01) were removed, reducing the number of probes analysed from 48,802 to 26,085.;GPL6884;Graham,J.,Mann;graham.mann@sydney.edu.au;Melanoma Institute Australia;Poche Centre, 40 Rocklands Road;North Sydney;NSW;2060;Australia;NONE;26085;Reanalysis of: GSM1282647;2;49;57;Alive NSR;Female;Stage I;219,42;115,36
0,347912455;0;0;0,073103098;0,016339002;0;0,562645445;GSM1315949;melanoma AJCCstageIII TumourID64;Public on Aug 18 2014;Jan 28 2014;Aug 18 2014;RNA;1;melanoma lymph node, fresh frozen tissue (>80% tumor cell content, <30% necrosis);Homo sapiens;patient age at primary diagnosis (years): 69;patient sex: Male;patient age at stage iii sample banked (years): 69;survival from stage iii tumour banked (months): 12.43;survival from primary melanoma (months): 14.89;patient last status: Dead Melanoma;number of primary melanomas: 1;stage at primary diagnosis 5th edition: Stage III;Tissue samples were homogenized using a high-speed agitation polytron blender (Kinematica, Luzern, Switzerland) in the presence of Trizol.;Total RNA was extracted from 20-30mg of fresh frozen tissue.;total RNA;The RNA was isolated and purified with an RNeasy purification kit (Qiagen RNeasy purification kit- Qiagen Pty Ltd., Clifton Hill, Victoria, Australia) with DNAse I digestion on the column. The quality of the RNA preparations was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA, USA). RNA integrity scores were >8 for all samples analyzed.;biotin;cRNA amplification and labelling with biotin were performed using Illumina TotalPrep RNA amplification kit according to the manufacturer’s directions (Ambion, Inc., Austin, TX, USA) with 250ng total RNA as input material.;9606;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Quality control was performed on all chips using R/Bioconductor and the lumi package (www.bioconductor.org). Data normalization was performed using a variance-stabilizing transform (VST) and quantile normalization as implemented in the lumi package for R/Bioconductor. To reduce false positives, unexpressed genes (detection p-value >0.01) were removed, reducing the number of probes analysed from 48,802 to 26,085.;GPL6884;Graham,J.,Mann;graham.mann@sydney.edu.au;Melanoma Institute Australia;Poche Centre, 40 Rocklands Road;North Sydney;NSW;2060;Australia;NONE;26085;Reanalysis of: GSM1282613;1;69;69;Dead Melanoma;Male;Stage III;14,89;12,43
0,1159155;0,138489832;0,014484486;0,043336229;0,028889395;0,163908919;0,49497564;GSM1315950;melanoma AJCCstageIII TumourID278;Public on Aug 18 2014;Jan 28 2014;Aug 18 2014;RNA;1;melanoma lymph node, fresh frozen tissue (>80% tumor cell content, <30% necrosis);Homo sapiens;patient age at primary diagnosis (years): 55;patient sex: Male;patient age at stage iii sample banked (years): 56;survival from stage iii tumour banked (months): 108.43;survival from primary melanoma (months): 109.55;patient last status: Alive NSR;number of primary melanomas: 1;stage at primary diagnosis 5th edition: Stage III;Tissue samples were homogenized using a high-speed agitation polytron blender (Kinematica, Luzern, Switzerland) in the presence of Trizol.;Total RNA was extracted from 20-30mg of fresh frozen tissue.;total RNA;The RNA was isolated and purified with an RNeasy purification kit (Qiagen RNeasy purification kit- Qiagen Pty Ltd., Clifton Hill, Victoria, Australia) with DNAse I digestion on the column. The quality of the RNA preparations was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA, USA). RNA integrity scores were >8 for all samples analyzed.;biotin;cRNA amplification and labelling with biotin were performed using Illumina TotalPrep RNA amplification kit according to the manufacturer’s directions (Ambion, Inc., Austin, TX, USA) with 250ng total RNA as input material.;9606;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Quality control was performed on all chips using R/Bioconductor and the lumi package (www.bioconductor.org). Data normalization was performed using a variance-stabilizing transform (VST) and quantile normalization as implemented in the lumi package for R/Bioconductor. To reduce false positives, unexpressed genes (detection p-value >0.01) were removed, reducing the number of probes analysed from 48,802 to 26,085.;GPL6884;Graham,J.,Mann;graham.mann@sydney.edu.au;Melanoma Institute Australia;Poche Centre, 40 Rocklands Road;North Sydney;NSW;2060;Australia;NONE;26085;Reanalysis of: GSM1282651;1;55;56;Alive NSR;Male;Stage III;109,55;108,43
0,173123656;0;0,104758593;0;0;0;0,72211775;GSM1315951;melanoma AJCCstageIII TumourID126;Public on Aug 18 2014;Jan 28 2014;Aug 18 2014;RNA;1;melanoma lymph node, fresh frozen tissue (>80% tumor cell content, <30% necrosis);Homo sapiens;patient age at primary diagnosis (years): 52;patient sex: Male;patient age at stage iii sample banked (years): 58;survival from stage iii tumour banked (months): 29.46;survival from primary melanoma (months): 103.27;patient last status: Dead Melanoma;number of primary melanomas: 1;stage at primary diagnosis 5th edition: Stage I;Tissue samples were homogenized using a high-speed agitation polytron blender (Kinematica, Luzern, Switzerland) in the presence of Trizol.;Total RNA was extracted from 20-30mg of fresh frozen tissue.;total RNA;The RNA was isolated and purified with an RNeasy purification kit (Qiagen RNeasy purification kit- Qiagen Pty Ltd., Clifton Hill, Victoria, Australia) with DNAse I digestion on the column. The quality of the RNA preparations was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA, USA). RNA integrity scores were >8 for all samples analyzed.;biotin;cRNA amplification and labelling with biotin were performed using Illumina TotalPrep RNA amplification kit according to the manufacturer’s directions (Ambion, Inc., Austin, TX, USA) with 250ng total RNA as input material.;9606;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Quality control was performed on all chips using R/Bioconductor and the lumi package (www.bioconductor.org). Data normalization was performed using a variance-stabilizing transform (VST) and quantile normalization as implemented in the lumi package for R/Bioconductor. To reduce false positives, unexpressed genes (detection p-value >0.01) were removed, reducing the number of probes analysed from 48,802 to 26,085.;GPL6884;Graham,J.,Mann;graham.mann@sydney.edu.au;Melanoma Institute Australia;Poche Centre, 40 Rocklands Road;North Sydney;NSW;2060;Australia;NONE;26085;Reanalysis of: GSM1282627;1;52;58;Dead Melanoma;Male;Stage I;103,27;29,46
0;0,053621024;0,020519917;0;0;0,52360213;0,402256929;GSM1315952;melanoma AJCCstageIII TumourID62;Public on Aug 18 2014;Jan 28 2014;Aug 18 2014;RNA;1;melanoma lymph node, fresh frozen tissue (>80% tumor cell content, <30% necrosis);Homo sapiens;patient age at primary diagnosis (years): 61;patient sex: Female;patient age at stage iii sample banked (years): 74;survival from stage iii tumour banked (months): 6.25;survival from primary melanoma (months): 156.26;patient last status: Dead Cause Unknown;number of primary melanomas: 1;stage at primary diagnosis 5th edition: Stage I;Tissue samples were homogenized using a high-speed agitation polytron blender (Kinematica, Luzern, Switzerland) in the presence of Trizol.;Total RNA was extracted from 20-30mg of fresh frozen tissue.;total RNA;The RNA was isolated and purified with an RNeasy purification kit (Qiagen RNeasy purification kit- Qiagen Pty Ltd., Clifton Hill, Victoria, Australia) with DNAse I digestion on the column. The quality of the RNA preparations was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA, USA). RNA integrity scores were >8 for all samples analyzed.;biotin;cRNA amplification and labelling with biotin were performed using Illumina TotalPrep RNA amplification kit according to the manufacturer’s directions (Ambion, Inc., Austin, TX, USA) with 250ng total RNA as input material.;9606;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Quality control was performed on all chips using R/Bioconductor and the lumi package (www.bioconductor.org). Data normalization was performed using a variance-stabilizing transform (VST) and quantile normalization as implemented in the lumi package for R/Bioconductor. To reduce false positives, unexpressed genes (detection p-value >0.01) were removed, reducing the number of probes analysed from 48,802 to 26,085.;GPL6884;Graham,J.,Mann;graham.mann@sydney.edu.au;Melanoma Institute Australia;Poche Centre, 40 Rocklands Road;North Sydney;NSW;2060;Australia;NONE;26085;Reanalysis of: GSM1282612;1;61;74;Dead Cause Unknown;Female;Stage I;156,26;6,25
0,132429282;0;0;0,075576285;0,021419001;0;0,770575432;GSM1315953;melanoma AJCCstageIII TumourID100;Public on Aug 18 2014;Jan 28 2014;Aug 18 2014;RNA;1;melanoma lymph node, fresh frozen tissue (>80% tumor cell content, <30% necrosis);Homo sapiens;patient age at primary diagnosis (years): 74;patient sex: Male;patient age at stage iii sample banked (years): 75;survival from stage iii tumour banked (months): 47.51;survival from primary melanoma (months): 61.51;patient last status: Dead Not Melanoma;number of primary melanomas: 1;stage at primary diagnosis 5th edition: Stage I;Tissue samples were homogenized using a high-speed agitation polytron blender (Kinematica, Luzern, Switzerland) in the presence of Trizol.;Total RNA was extracted from 20-30mg of fresh frozen tissue.;total RNA;The RNA was isolated and purified with an RNeasy purification kit (Qiagen RNeasy purification kit- Qiagen Pty Ltd., Clifton Hill, Victoria, Australia) with DNAse I digestion on the column. The quality of the RNA preparations was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA, USA). RNA integrity scores were >8 for all samples analyzed.;biotin;cRNA amplification and labelling with biotin were performed using Illumina TotalPrep RNA amplification kit according to the manufacturer’s directions (Ambion, Inc., Austin, TX, USA) with 250ng total RNA as input material.;9606;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Quality control was performed on all chips using R/Bioconductor and the lumi package (www.bioconductor.org). Data normalization was performed using a variance-stabilizing transform (VST) and quantile normalization as implemented in the lumi package for R/Bioconductor. To reduce false positives, unexpressed genes (detection p-value >0.01) were removed, reducing the number of probes analysed from 48,802 to 26,085.;GPL6884;Graham,J.,Mann;graham.mann@sydney.edu.au;Melanoma Institute Australia;Poche Centre, 40 Rocklands Road;North Sydney;NSW;2060;Australia;NONE;26085;Reanalysis of: GSM1282621;1;74;75;Dead Not Melanoma;Male;Stage I;61,51;47,51
0,073802057;0,036782198;0,043849269;0,043023764;0,00900747;0,266847289;0,526687955;GSM1315954;melanoma AJCCstageIII TumourID173;Public on Aug 18 2014;Jan 28 2014;Aug 18 2014;RNA;1;melanoma lymph node, fresh frozen tissue (>80% tumor cell content, <30% necrosis);Homo sapiens;patient age at primary diagnosis (years): 40;patient sex: Male;patient age at stage iii sample banked (years): 40;survival from stage iii tumour banked (months): 96.39;survival from primary melanoma (months): 97.22;patient last status: Alive NSR;number of primary melanomas: 1;stage at primary diagnosis 5th edition: Stage III;Tissue samples were homogenized using a high-speed agitation polytron blender (Kinematica, Luzern, Switzerland) in the presence of Trizol.;Total RNA was extracted from 20-30mg of fresh frozen tissue.;total RNA;The RNA was isolated and purified with an RNeasy purification kit (Qiagen RNeasy purification kit- Qiagen Pty Ltd., Clifton Hill, Victoria, Australia) with DNAse I digestion on the column. The quality of the RNA preparations was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA, USA). RNA integrity scores were >8 for all samples analyzed.;biotin;cRNA amplification and labelling with biotin were performed using Illumina TotalPrep RNA amplification kit according to the manufacturer’s directions (Ambion, Inc., Austin, TX, USA) with 250ng total RNA as input material.;9606;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Quality control was performed on all chips using R/Bioconductor and the lumi package (www.bioconductor.org). Data normalization was performed using a variance-stabilizing transform (VST) and quantile normalization as implemented in the lumi package for R/Bioconductor. To reduce false positives, unexpressed genes (detection p-value >0.01) were removed, reducing the number of probes analysed from 48,802 to 26,085.;GPL6884;Graham,J.,Mann;graham.mann@sydney.edu.au;Melanoma Institute Australia;Poche Centre, 40 Rocklands Road;North Sydney;NSW;2060;Australia;NONE;26085;Reanalysis of: GSM1282633;1;40;40;Alive NSR;Male;Stage III;97,22;96,39
0,114638334;0;0,001143349;0,092711741;0,010823174;0,148382114;0,632301289;GSM1315955;melanoma AJCCstageIII TumourID219;Public on Aug 18 2014;Jan 28 2014;Aug 18 2014;RNA;1;melanoma lymph node, fresh frozen tissue (>80% tumor cell content, <30% necrosis);Homo sapiens;patient age at primary diagnosis (years): 36;patient sex: Male;patient age at stage iii sample banked (years): 44;survival from stage iii tumour banked (months): 116.28;survival from primary melanoma (months): 208.08;patient last status: Alive with Melanoma;number of primary melanomas: 1;stage at primary diagnosis 5th edition: Stage II;Tissue samples were homogenized using a high-speed agitation polytron blender (Kinematica, Luzern, Switzerland) in the presence of Trizol.;Total RNA was extracted from 20-30mg of fresh frozen tissue.;total RNA;The RNA was isolated and purified with an RNeasy purification kit (Qiagen RNeasy purification kit- Qiagen Pty Ltd., Clifton Hill, Victoria, Australia) with DNAse I digestion on the column. The quality of the RNA preparations was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA, USA). RNA integrity scores were >8 for all samples analyzed.;biotin;cRNA amplification and labelling with biotin were performed using Illumina TotalPrep RNA amplification kit according to the manufacturer’s directions (Ambion, Inc., Austin, TX, USA) with 250ng total RNA as input material.;9606;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Quality control was performed on all chips using R/Bioconductor and the lumi package (www.bioconductor.org). Data normalization was performed using a variance-stabilizing transform (VST) and quantile normalization as implemented in the lumi package for R/Bioconductor. To reduce false positives, unexpressed genes (detection p-value >0.01) were removed, reducing the number of probes analysed from 48,802 to 26,085.;GPL6884;Graham,J.,Mann;graham.mann@sydney.edu.au;Melanoma Institute Australia;Poche Centre, 40 Rocklands Road;North Sydney;NSW;2060;Australia;NONE;26085;Reanalysis of: GSM1282640;1;36;44;Alive with Melanoma;Male;Stage II;208,08;116,28
0,188771849;0;0;0,08913279;0,022622241;0;0,69947312;GSM1315956;melanoma AJCCstageIII TumourID74;Public on Aug 18 2014;Jan 28 2014;Aug 18 2014;RNA;1;melanoma lymph node, fresh frozen tissue (>80% tumor cell content, <30% necrosis);Homo sapiens;patient age at primary diagnosis (years): 70;patient sex: Female;patient age at stage iii sample banked (years): 73;survival from stage iii tumour banked (months): 94.85;survival from primary melanoma (months): 128.71;patient last status: Alive NSR;number of primary melanomas: 1;stage at primary diagnosis 5th edition: Stage II;Tissue samples were homogenized using a high-speed agitation polytron blender (Kinematica, Luzern, Switzerland) in the presence of Trizol.;Total RNA was extracted from 20-30mg of fresh frozen tissue.;total RNA;The RNA was isolated and purified with an RNeasy purification kit (Qiagen RNeasy purification kit- Qiagen Pty Ltd., Clifton Hill, Victoria, Australia) with DNAse I digestion on the column. The quality of the RNA preparations was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA, USA). RNA integrity scores were >8 for all samples analyzed.;biotin;cRNA amplification and labelling with biotin were performed using Illumina TotalPrep RNA amplification kit according to the manufacturer’s directions (Ambion, Inc., Austin, TX, USA) with 250ng total RNA as input material.;9606;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Quality control was performed on all chips using R/Bioconductor and the lumi package (www.bioconductor.org). Data normalization was performed using a variance-stabilizing transform (VST) and quantile normalization as implemented in the lumi package for R/Bioconductor. To reduce false positives, unexpressed genes (detection p-value >0.01) were removed, reducing the number of probes analysed from 48,802 to 26,085.;GPL6884;Graham,J.,Mann;graham.mann@sydney.edu.au;Melanoma Institute Australia;Poche Centre, 40 Rocklands Road;North Sydney;NSW;2060;Australia;NONE;26085;Reanalysis of: GSM1282616;1;70;73;Alive NSR;Female;Stage II;128,71;94,85
0,335021301;0;0;0;0;0;0,664978699;GSM1315957;melanoma AJCCstageIII TumourID54;Public on Aug 18 2014;Jan 28 2014;Aug 18 2014;RNA;1;melanoma lymph node, fresh frozen tissue (>80% tumor cell content, <30% necrosis);Homo sapiens;patient age at primary diagnosis (years): 67;patient sex: Male;patient age at stage iii sample banked (years): 67;survival from stage iii tumour banked (months): 39.45;survival from primary melanoma (months): 40.64;patient last status: Alive NSR;number of primary melanomas: 1;stage at primary diagnosis 5th edition: Stage III;Tissue samples were homogenized using a high-speed agitation polytron blender (Kinematica, Luzern, Switzerland) in the presence of Trizol.;Total RNA was extracted from 20-30mg of fresh frozen tissue.;total RNA;The RNA was isolated and purified with an RNeasy purification kit (Qiagen RNeasy purification kit- Qiagen Pty Ltd., Clifton Hill, Victoria, Australia) with DNAse I digestion on the column. The quality of the RNA preparations was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA, USA). RNA integrity scores were >8 for all samples analyzed.;biotin;cRNA amplification and labelling with biotin were performed using Illumina TotalPrep RNA amplification kit according to the manufacturer’s directions (Ambion, Inc., Austin, TX, USA) with 250ng total RNA as input material.;9606;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Quality control was performed on all chips using R/Bioconductor and the lumi package (www.bioconductor.org). Data normalization was performed using a variance-stabilizing transform (VST) and quantile normalization as implemented in the lumi package for R/Bioconductor. To reduce false positives, unexpressed genes (detection p-value >0.01) were removed, reducing the number of probes analysed from 48,802 to 26,085.;GPL6884;Graham,J.,Mann;graham.mann@sydney.edu.au;Melanoma Institute Australia;Poche Centre, 40 Rocklands Road;North Sydney;NSW;2060;Australia;NONE;26085;Reanalysis of: GSM1282610;1;67;67;Alive NSR;Male;Stage III;40,64;39,45
0,143201175;0,078392472;0,025316462;0,032584886;0,016718837;0,27753211;0,426254057;GSM1315958;melanoma AJCCstageIII TumourID149;Public on Aug 18 2014;Jan 28 2014;Aug 18 2014;RNA;1;melanoma lymph node, fresh frozen tissue (>80% tumor cell content, <30% necrosis);Homo sapiens;patient age at primary diagnosis (years): 53;patient sex: Male;patient age at stage iii sample banked (years): 66;survival from stage iii tumour banked (months): 14.93;survival from primary melanoma (months): 175.07;patient last status: Dead Melanoma;number of primary melanomas: 1;stage at primary diagnosis 5th edition: Stage I;Tissue samples were homogenized using a high-speed agitation polytron blender (Kinematica, Luzern, Switzerland) in the presence of Trizol.;Total RNA was extracted from 20-30mg of fresh frozen tissue.;total RNA;The RNA was isolated and purified with an RNeasy purification kit (Qiagen RNeasy purification kit- Qiagen Pty Ltd., Clifton Hill, Victoria, Australia) with DNAse I digestion on the column. The quality of the RNA preparations was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA, USA). RNA integrity scores were >8 for all samples analyzed.;biotin;cRNA amplification and labelling with biotin were performed using Illumina TotalPrep RNA amplification kit according to the manufacturer’s directions (Ambion, Inc., Austin, TX, USA) with 250ng total RNA as input material.;9606;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Quality control was performed on all chips using R/Bioconductor and the lumi package (www.bioconductor.org). Data normalization was performed using a variance-stabilizing transform (VST) and quantile normalization as implemented in the lumi package for R/Bioconductor. To reduce false positives, unexpressed genes (detection p-value >0.01) were removed, reducing the number of probes analysed from 48,802 to 26,085.;GPL6884;Graham,J.,Mann;graham.mann@sydney.edu.au;Melanoma Institute Australia;Poche Centre, 40 Rocklands Road;North Sydney;NSW;2060;Australia;NONE;26085;Reanalysis of: GSM1282630;1;53;66;Dead Melanoma;Male;Stage I;175,07;14,93
0,308092435;0,048483316;0,002860926;0;0;0,044338046;0,596225277;GSM1315959;melanoma AJCCstageIII TumourID88;Public on Aug 18 2014;Jan 28 2014;Aug 18 2014;RNA;1;melanoma lymph node, fresh frozen tissue (>80% tumor cell content, <30% necrosis);Homo sapiens;patient age at primary diagnosis (years): 64;patient sex: Female;patient age at stage iii sample banked (years): 64;survival from stage iii tumour banked (months): 120.00;survival from primary melanoma (months): 121.12;patient last status: Alive NSR;number of primary melanomas: 1;stage at primary diagnosis 5th edition: Stage III;Tissue samples were homogenized using a high-speed agitation polytron blender (Kinematica, Luzern, Switzerland) in the presence of Trizol.;Total RNA was extracted from 20-30mg of fresh frozen tissue.;total RNA;The RNA was isolated and purified with an RNeasy purification kit (Qiagen RNeasy purification kit- Qiagen Pty Ltd., Clifton Hill, Victoria, Australia) with DNAse I digestion on the column. The quality of the RNA preparations was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA, USA). RNA integrity scores were >8 for all samples analyzed.;biotin;cRNA amplification and labelling with biotin were performed using Illumina TotalPrep RNA amplification kit according to the manufacturer’s directions (Ambion, Inc., Austin, TX, USA) with 250ng total RNA as input material.;9606;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Quality control was performed on all chips using R/Bioconductor and the lumi package (www.bioconductor.org). Data normalization was performed using a variance-stabilizing transform (VST) and quantile normalization as implemented in the lumi package for R/Bioconductor. To reduce false positives, unexpressed genes (detection p-value >0.01) were removed, reducing the number of probes analysed from 48,802 to 26,085.;GPL6884;Graham,J.,Mann;graham.mann@sydney.edu.au;Melanoma Institute Australia;Poche Centre, 40 Rocklands Road;North Sydney;NSW;2060;Australia;NONE;26085;Reanalysis of: GSM1282618;1;64;64;Alive NSR;Female;Stage III;121,12;120
0,203341529;0;0;0,121163536;0,038399174;0;0,637095761;GSM1315960;melanoma AJCCstageIII TumourID32;Public on Aug 18 2014;Jan 28 2014;Aug 18 2014;RNA;1;melanoma lymph node, fresh frozen tissue (>80% tumor cell content, <30% necrosis);Homo sapiens;patient age at primary diagnosis (years): 59;patient sex: Male;patient age at stage iii sample banked (years): 61;survival from stage iii tumour banked (months): 143.24;survival from primary melanoma (months): 170.89;patient last status: Alive NSR;number of primary melanomas: 1;stage at primary diagnosis 5th edition: Stage I;Tissue samples were homogenized using a high-speed agitation polytron blender (Kinematica, Luzern, Switzerland) in the presence of Trizol.;Total RNA was extracted from 20-30mg of fresh frozen tissue.;total RNA;The RNA was isolated and purified with an RNeasy purification kit (Qiagen RNeasy purification kit- Qiagen Pty Ltd., Clifton Hill, Victoria, Australia) with DNAse I digestion on the column. The quality of the RNA preparations was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA, USA). RNA integrity scores were >8 for all samples analyzed.;biotin;cRNA amplification and labelling with biotin were performed using Illumina TotalPrep RNA amplification kit according to the manufacturer’s directions (Ambion, Inc., Austin, TX, USA) with 250ng total RNA as input material.;9606;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Quality control was performed on all chips using R/Bioconductor and the lumi package (www.bioconductor.org). Data normalization was performed using a variance-stabilizing transform (VST) and quantile normalization as implemented in the lumi package for R/Bioconductor. To reduce false positives, unexpressed genes (detection p-value >0.01) were removed, reducing the number of probes analysed from 48,802 to 26,085.;GPL6884;Graham,J.,Mann;graham.mann@sydney.edu.au;Melanoma Institute Australia;Poche Centre, 40 Rocklands Road;North Sydney;NSW;2060;Australia;NONE;26085;Reanalysis of: GSM1282600;1;59;61;Alive NSR;Male;Stage I;170,89;143,24
0,214319281;0;0;0,101359785;0,015151807;0,034432986;0,634736141;GSM1315961;melanoma AJCCstageIII TumourID25;Public on Aug 18 2014;Jan 28 2014;Aug 18 2014;RNA;1;melanoma lymph node, fresh frozen tissue (>80% tumor cell content, <30% necrosis);Homo sapiens;patient age at primary diagnosis (years): 78;patient sex: Male;patient age at stage iii sample banked (years): 88;survival from stage iii tumour banked (months): 113.06;survival from primary melanoma (months): 230.14;patient last status: Dead Cause Unknown;number of primary melanomas: 1;stage at primary diagnosis 5th edition: Stage I;Tissue samples were homogenized using a high-speed agitation polytron blender (Kinematica, Luzern, Switzerland) in the presence of Trizol.;Total RNA was extracted from 20-30mg of fresh frozen tissue.;total RNA;The RNA was isolated and purified with an RNeasy purification kit (Qiagen RNeasy purification kit- Qiagen Pty Ltd., Clifton Hill, Victoria, Australia) with DNAse I digestion on the column. The quality of the RNA preparations was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA, USA). RNA integrity scores were >8 for all samples analyzed.;biotin;cRNA amplification and labelling with biotin were performed using Illumina TotalPrep RNA amplification kit according to the manufacturer’s directions (Ambion, Inc., Austin, TX, USA) with 250ng total RNA as input material.;9606;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Quality control was performed on all chips using R/Bioconductor and the lumi package (www.bioconductor.org). Data normalization was performed using a variance-stabilizing transform (VST) and quantile normalization as implemented in the lumi package for R/Bioconductor. To reduce false positives, unexpressed genes (detection p-value >0.01) were removed, reducing the number of probes analysed from 48,802 to 26,085.;GPL6884;Graham,J.,Mann;graham.mann@sydney.edu.au;Melanoma Institute Australia;Poche Centre, 40 Rocklands Road;North Sydney;NSW;2060;Australia;NONE;26085;Reanalysis of: GSM1282597;1;78;88;Dead Cause Unknown;Male;Stage I;230,14;113,06
0,161825528;0;0;0,136249545;0,02865008;0;0,673274847;GSM1315962;melanoma AJCCstageIII TumourID37;Public on Aug 18 2014;Jan 28 2014;Aug 18 2014;RNA;1;melanoma lymph node, fresh frozen tissue (>80% tumor cell content, <30% necrosis);Homo sapiens;patient age at primary diagnosis (years): 62;patient sex: Male;patient age at stage iii sample banked (years): 64;survival from stage iii tumour banked (months): 97.61;survival from primary melanoma (months): 129.27;patient last status: Alive NSR;number of primary melanomas: 1;stage at primary diagnosis 5th edition: Stage I;Tissue samples were homogenized using a high-speed agitation polytron blender (Kinematica, Luzern, Switzerland) in the presence of Trizol.;Total RNA was extracted from 20-30mg of fresh frozen tissue.;total RNA;The RNA was isolated and purified with an RNeasy purification kit (Qiagen RNeasy purification kit- Qiagen Pty Ltd., Clifton Hill, Victoria, Australia) with DNAse I digestion on the column. The quality of the RNA preparations was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA, USA). RNA integrity scores were >8 for all samples analyzed.;biotin;cRNA amplification and labelling with biotin were performed using Illumina TotalPrep RNA amplification kit according to the manufacturer’s directions (Ambion, Inc., Austin, TX, USA) with 250ng total RNA as input material.;9606;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Quality control was performed on all chips using R/Bioconductor and the lumi package (www.bioconductor.org). Data normalization was performed using a variance-stabilizing transform (VST) and quantile normalization as implemented in the lumi package for R/Bioconductor. To reduce false positives, unexpressed genes (detection p-value >0.01) were removed, reducing the number of probes analysed from 48,802 to 26,085.;GPL6884;Graham,J.,Mann;graham.mann@sydney.edu.au;Melanoma Institute Australia;Poche Centre, 40 Rocklands Road;North Sydney;NSW;2060;Australia;NONE;26085;Reanalysis of: GSM1282602;1;62;64;Alive NSR;Male;Stage I;129,27;97,61
0,219669343;0,04751412;0,06123314;0,081955565;0,082408148;0;0,507219684;GSM1315963;melanoma AJCCstageIII TumourID351;Public on Aug 18 2014;Jan 28 2014;Aug 18 2014;RNA;1;melanoma lymph node, fresh frozen tissue (>80% tumor cell content, <30% necrosis);Homo sapiens;patient age at primary diagnosis (years): 30;patient sex: Male;patient age at stage iii sample banked (years): 63;survival from stage iii tumour banked (months): 6.61;survival from primary melanoma (months): 403.13;patient last status: Dead Melanoma;number of primary melanomas: 1;stage at primary diagnosis 5th edition: Stage I;Tissue samples were homogenized using a high-speed agitation polytron blender (Kinematica, Luzern, Switzerland) in the presence of Trizol.;Total RNA was extracted from 20-30mg of fresh frozen tissue.;total RNA;The RNA was isolated and purified with an RNeasy purification kit (Qiagen RNeasy purification kit- Qiagen Pty Ltd., Clifton Hill, Victoria, Australia) with DNAse I digestion on the column. The quality of the RNA preparations was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA, USA). RNA integrity scores were >8 for all samples analyzed.;biotin;cRNA amplification and labelling with biotin were performed using Illumina TotalPrep RNA amplification kit according to the manufacturer’s directions (Ambion, Inc., Austin, TX, USA) with 250ng total RNA as input material.;9606;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Quality control was performed on all chips using R/Bioconductor and the lumi package (www.bioconductor.org). Data normalization was performed using a variance-stabilizing transform (VST) and quantile normalization as implemented in the lumi package for R/Bioconductor. To reduce false positives, unexpressed genes (detection p-value >0.01) were removed, reducing the number of probes analysed from 48,802 to 26,085.;GPL6884;Graham,J.,Mann;graham.mann@sydney.edu.au;Melanoma Institute Australia;Poche Centre, 40 Rocklands Road;North Sydney;NSW;2060;Australia;NONE;26085;Reanalysis of: GSM1282660;1;30;63;Dead Melanoma;Male;Stage I;403,13;6,61
0,149762187;0,065940887;0,044775245;0,131894921;0,039066543;0,11584242;0,452717796;GSM1315964;melanoma AJCCstageIII TumourID61;Public on Aug 18 2014;Jan 28 2014;Aug 18 2014;RNA;1;melanoma lymph node, fresh frozen tissue (>80% tumor cell content, <30% necrosis);Homo sapiens;patient age at primary diagnosis (years): 40;patient sex: Female;patient age at stage iii sample banked (years): 46;survival from stage iii tumour banked (months): 5.79;survival from primary melanoma (months): 73.61;patient last status: Dead Melanoma;number of primary melanomas: 1;stage at primary diagnosis 5th edition: Stage III;Tissue samples were homogenized using a high-speed agitation polytron blender (Kinematica, Luzern, Switzerland) in the presence of Trizol.;Total RNA was extracted from 20-30mg of fresh frozen tissue.;total RNA;The RNA was isolated and purified with an RNeasy purification kit (Qiagen RNeasy purification kit- Qiagen Pty Ltd., Clifton Hill, Victoria, Australia) with DNAse I digestion on the column. The quality of the RNA preparations was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA, USA). RNA integrity scores were >8 for all samples analyzed.;biotin;cRNA amplification and labelling with biotin were performed using Illumina TotalPrep RNA amplification kit according to the manufacturer’s directions (Ambion, Inc., Austin, TX, USA) with 250ng total RNA as input material.;9606;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Quality control was performed on all chips using R/Bioconductor and the lumi package (www.bioconductor.org). Data normalization was performed using a variance-stabilizing transform (VST) and quantile normalization as implemented in the lumi package for R/Bioconductor. To reduce false positives, unexpressed genes (detection p-value >0.01) were removed, reducing the number of probes analysed from 48,802 to 26,085.;GPL6884;Graham,J.,Mann;graham.mann@sydney.edu.au;Melanoma Institute Australia;Poche Centre, 40 Rocklands Road;North Sydney;NSW;2060;Australia;NONE;26085;Reanalysis of: GSM1282611;1;40;46;Dead Melanoma;Female;Stage III;73,61;5,79
0,271484111;0,006832078;0;0,001114404;0;0,051533926;0,669035481;GSM1315965;melanoma AJCCstageIII TumourID259;Public on Aug 18 2014;Jan 28 2014;Aug 18 2014;RNA;1;melanoma lymph node, fresh frozen tissue (>80% tumor cell content, <30% necrosis);Homo sapiens;patient age at primary diagnosis (years): 58;patient sex: Female;patient age at stage iii sample banked (years): 63;survival from stage iii tumour banked (months): 62.07;survival from primary melanoma (months): 122.17;patient last status: Dead Melanoma;number of primary melanomas: 1;stage at primary diagnosis 5th edition: Stage II;Tissue samples were homogenized using a high-speed agitation polytron blender (Kinematica, Luzern, Switzerland) in the presence of Trizol.;Total RNA was extracted from 20-30mg of fresh frozen tissue.;total RNA;The RNA was isolated and purified with an RNeasy purification kit (Qiagen RNeasy purification kit- Qiagen Pty Ltd., Clifton Hill, Victoria, Australia) with DNAse I digestion on the column. The quality of the RNA preparations was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA, USA). RNA integrity scores were >8 for all samples analyzed.;biotin;cRNA amplification and labelling with biotin were performed using Illumina TotalPrep RNA amplification kit according to the manufacturer’s directions (Ambion, Inc., Austin, TX, USA) with 250ng total RNA as input material.;9606;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Quality control was performed on all chips using R/Bioconductor and the lumi package (www.bioconductor.org). Data normalization was performed using a variance-stabilizing transform (VST) and quantile normalization as implemented in the lumi package for R/Bioconductor. To reduce false positives, unexpressed genes (detection p-value >0.01) were removed, reducing the number of probes analysed from 48,802 to 26,085.;GPL6884;Graham,J.,Mann;graham.mann@sydney.edu.au;Melanoma Institute Australia;Poche Centre, 40 Rocklands Road;North Sydney;NSW;2060;Australia;NONE;26085;Reanalysis of: GSM1282648;1;58;63;Dead Melanoma;Female;Stage II;122,17;62,07
0,195579105;0;0;0,078169635;0,002460794;0;0,723790466;GSM1315966;melanoma AJCCstageIII TumourID45;Public on Aug 18 2014;Jan 28 2014;Aug 18 2014;RNA;1;melanoma lymph node, fresh frozen tissue (>80% tumor cell content, <30% necrosis);Homo sapiens;patient age at primary diagnosis (years): 39;patient sex: Female;patient age at stage iii sample banked (years): 40;survival from stage iii tumour banked (months): 97.78;survival from primary melanoma (months): 114.38;patient last status: Alive NSR;number of primary melanomas: 1;stage at primary diagnosis 5th edition: Stage I;Tissue samples were homogenized using a high-speed agitation polytron blender (Kinematica, Luzern, Switzerland) in the presence of Trizol.;Total RNA was extracted from 20-30mg of fresh frozen tissue.;total RNA;The RNA was isolated and purified with an RNeasy purification kit (Qiagen RNeasy purification kit- Qiagen Pty Ltd., Clifton Hill, Victoria, Australia) with DNAse I digestion on the column. The quality of the RNA preparations was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA, USA). RNA integrity scores were >8 for all samples analyzed.;biotin;cRNA amplification and labelling with biotin were performed using Illumina TotalPrep RNA amplification kit according to the manufacturer’s directions (Ambion, Inc., Austin, TX, USA) with 250ng total RNA as input material.;9606;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Quality control was performed on all chips using R/Bioconductor and the lumi package (www.bioconductor.org). Data normalization was performed using a variance-stabilizing transform (VST) and quantile normalization as implemented in the lumi package for R/Bioconductor. To reduce false positives, unexpressed genes (detection p-value >0.01) were removed, reducing the number of probes analysed from 48,802 to 26,085.;GPL6884;Graham,J.,Mann;graham.mann@sydney.edu.au;Melanoma Institute Australia;Poche Centre, 40 Rocklands Road;North Sydney;NSW;2060;Australia;NONE;26085;Reanalysis of: GSM1282604;1;39;40;Alive NSR;Female;Stage I;114,38;97,78
0,015159988;0,04143583;0;0,015263148;0,042544243;0,193727875;0,691868916;GSM1315967;melanoma AJCCstageIII TumourID30;Public on Aug 18 2014;Jan 28 2014;Aug 18 2014;RNA;1;melanoma lymph node, fresh frozen tissue (>80% tumor cell content, <30% necrosis);Homo sapiens;patient age at primary diagnosis (years): 49;patient sex: Male;patient age at stage iii sample banked (years): 50;survival from stage iii tumour banked (months): 8.42;survival from primary melanoma (months): 21.67;patient last status: Dead Melanoma;number of primary melanomas: 1;stage at primary diagnosis 5th edition: Stage I;Tissue samples were homogenized using a high-speed agitation polytron blender (Kinematica, Luzern, Switzerland) in the presence of Trizol.;Total RNA was extracted from 20-30mg of fresh frozen tissue.;total RNA;The RNA was isolated and purified with an RNeasy purification kit (Qiagen RNeasy purification kit- Qiagen Pty Ltd., Clifton Hill, Victoria, Australia) with DNAse I digestion on the column. The quality of the RNA preparations was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA, USA). RNA integrity scores were >8 for all samples analyzed.;biotin;cRNA amplification and labelling with biotin were performed using Illumina TotalPrep RNA amplification kit according to the manufacturer’s directions (Ambion, Inc., Austin, TX, USA) with 250ng total RNA as input material.;9606;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Quality control was performed on all chips using R/Bioconductor and the lumi package (www.bioconductor.org). Data normalization was performed using a variance-stabilizing transform (VST) and quantile normalization as implemented in the lumi package for R/Bioconductor. To reduce false positives, unexpressed genes (detection p-value >0.01) were removed, reducing the number of probes analysed from 48,802 to 26,085.;GPL6884;Graham,J.,Mann;graham.mann@sydney.edu.au;Melanoma Institute Australia;Poche Centre, 40 Rocklands Road;North Sydney;NSW;2060;Australia;NONE;26085;Reanalysis of: GSM1282599;1;49;50;Dead Melanoma;Male;Stage I;21,67;8,42
0,231470879;0;0;0,023479013;0,016556186;0;0,728493922;GSM1315968;melanoma AJCCstageIII TumourID103;Public on Aug 18 2014;Jan 28 2014;Aug 18 2014;RNA;1;melanoma lymph node, fresh frozen tissue (>80% tumor cell content, <30% necrosis);Homo sapiens;patient age at primary diagnosis (years): 50;patient sex: Male;patient age at stage iii sample banked (years): 51;survival from stage iii tumour banked (months): 123.91;survival from primary melanoma (months): 144.49;patient last status: Alive NSR;number of primary melanomas: 3;stage at primary diagnosis 5th edition: Stage II;Tissue samples were homogenized using a high-speed agitation polytron blender (Kinematica, Luzern, Switzerland) in the presence of Trizol.;Total RNA was extracted from 20-30mg of fresh frozen tissue.;total RNA;The RNA was isolated and purified with an RNeasy purification kit (Qiagen RNeasy purification kit- Qiagen Pty Ltd., Clifton Hill, Victoria, Australia) with DNAse I digestion on the column. The quality of the RNA preparations was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA, USA). RNA integrity scores were >8 for all samples analyzed.;biotin;cRNA amplification and labelling with biotin were performed using Illumina TotalPrep RNA amplification kit according to the manufacturer’s directions (Ambion, Inc., Austin, TX, USA) with 250ng total RNA as input material.;9606;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Quality control was performed on all chips using R/Bioconductor and the lumi package (www.bioconductor.org). Data normalization was performed using a variance-stabilizing transform (VST) and quantile normalization as implemented in the lumi package for R/Bioconductor. To reduce false positives, unexpressed genes (detection p-value >0.01) were removed, reducing the number of probes analysed from 48,802 to 26,085.;GPL6884;Graham,J.,Mann;graham.mann@sydney.edu.au;Melanoma Institute Australia;Poche Centre, 40 Rocklands Road;North Sydney;NSW;2060;Australia;NONE;26085;Reanalysis of: GSM1282623;3;50;51;Alive NSR;Male;Stage II;144,49;123,91
0,131117898;0;0;0,080463024;0,035765721;0,115753428;0,63689993;GSM1315969;melanoma AJCCstageIII TumourID231;Public on Aug 18 2014;Jan 28 2014;Aug 18 2014;RNA;1;melanoma lymph node, fresh frozen tissue (>80% tumor cell content, <30% necrosis);Homo sapiens;patient age at primary diagnosis (years): 24;patient sex: Male;patient age at stage iii sample banked (years): 24;survival from stage iii tumour banked (months): 41.13;survival from primary melanoma (months): 41.88;patient last status: Alive NSR;number of primary melanomas: 1;stage at primary diagnosis 5th edition: Stage III;Tissue samples were homogenized using a high-speed agitation polytron blender (Kinematica, Luzern, Switzerland) in the presence of Trizol.;Total RNA was extracted from 20-30mg of fresh frozen tissue.;total RNA;The RNA was isolated and purified with an RNeasy purification kit (Qiagen RNeasy purification kit- Qiagen Pty Ltd., Clifton Hill, Victoria, Australia) with DNAse I digestion on the column. The quality of the RNA preparations was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA, USA). RNA integrity scores were >8 for all samples analyzed.;biotin;cRNA amplification and labelling with biotin were performed using Illumina TotalPrep RNA amplification kit according to the manufacturer’s directions (Ambion, Inc., Austin, TX, USA) with 250ng total RNA as input material.;9606;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Quality control was performed on all chips using R/Bioconductor and the lumi package (www.bioconductor.org). Data normalization was performed using a variance-stabilizing transform (VST) and quantile normalization as implemented in the lumi package for R/Bioconductor. To reduce false positives, unexpressed genes (detection p-value >0.01) were removed, reducing the number of probes analysed from 48,802 to 26,085.;GPL6884;Graham,J.,Mann;graham.mann@sydney.edu.au;Melanoma Institute Australia;Poche Centre, 40 Rocklands Road;North Sydney;NSW;2060;Australia;NONE;26085;Reanalysis of: GSM1282641;1;24;24;Alive NSR;Male;Stage III;41,88;41,13
0,03363382;0,003732002;0,012652089;0;0;0,334079476;0,615902613;GSM1315970;melanoma AJCCstageIII TumourID396;Public on Aug 18 2014;Jan 28 2014;Aug 18 2014;RNA;1;melanoma lymph node, fresh frozen tissue (>80% tumor cell content, <30% necrosis);Homo sapiens;patient age at primary diagnosis (years): 70;patient sex: Female;patient age at stage iii sample banked (years): 73;survival from stage iii tumour banked (months): 62.07;survival from primary melanoma (months): 92.75;patient last status: Alive NSR;number of primary melanomas: 1;stage at primary diagnosis 5th edition: Stage II;Tissue samples were homogenized using a high-speed agitation polytron blender (Kinematica, Luzern, Switzerland) in the presence of Trizol.;Total RNA was extracted from 20-30mg of fresh frozen tissue.;total RNA;The RNA was isolated and purified with an RNeasy purification kit (Qiagen RNeasy purification kit- Qiagen Pty Ltd., Clifton Hill, Victoria, Australia) with DNAse I digestion on the column. The quality of the RNA preparations was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA, USA). RNA integrity scores were >8 for all samples analyzed.;biotin;cRNA amplification and labelling with biotin were performed using Illumina TotalPrep RNA amplification kit according to the manufacturer’s directions (Ambion, Inc., Austin, TX, USA) with 250ng total RNA as input material.;9606;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Quality control was performed on all chips using R/Bioconductor and the lumi package (www.bioconductor.org). Data normalization was performed using a variance-stabilizing transform (VST) and quantile normalization as implemented in the lumi package for R/Bioconductor. To reduce false positives, unexpressed genes (detection p-value >0.01) were removed, reducing the number of probes analysed from 48,802 to 26,085.;GPL6884;Graham,J.,Mann;graham.mann@sydney.edu.au;Melanoma Institute Australia;Poche Centre, 40 Rocklands Road;North Sydney;NSW;2060;Australia;NONE;26085;Reanalysis of: GSM1282667;1;70;73;Alive NSR;Female;Stage II;92,75;62,07
0,303742139;0;0;0;0;0;0,696257861;GSM1315971;melanoma AJCCstageIII TumourID5;Public on Aug 18 2014;Jan 28 2014;Aug 18 2014;RNA;1;melanoma lymph node, fresh frozen tissue (>80% tumor cell content, <30% necrosis);Homo sapiens;patient age at primary diagnosis (years): 83;patient sex: Male;patient age at stage iii sample banked (years): 86;survival from stage iii tumour banked (months): 26.70;survival from primary melanoma (months): 62.50;patient last status: Dead Not Melanoma;number of primary melanomas: 1;stage at primary diagnosis 5th edition: Stage II;Tissue samples were homogenized using a high-speed agitation polytron blender (Kinematica, Luzern, Switzerland) in the presence of Trizol.;Total RNA was extracted from 20-30mg of fresh frozen tissue.;total RNA;The RNA was isolated and purified with an RNeasy purification kit (Qiagen RNeasy purification kit- Qiagen Pty Ltd., Clifton Hill, Victoria, Australia) with DNAse I digestion on the column. The quality of the RNA preparations was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA, USA). RNA integrity scores were >8 for all samples analyzed.;biotin;cRNA amplification and labelling with biotin were performed using Illumina TotalPrep RNA amplification kit according to the manufacturer’s directions (Ambion, Inc., Austin, TX, USA) with 250ng total RNA as input material.;9606;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Quality control was performed on all chips using R/Bioconductor and the lumi package (www.bioconductor.org). Data normalization was performed using a variance-stabilizing transform (VST) and quantile normalization as implemented in the lumi package for R/Bioconductor. To reduce false positives, unexpressed genes (detection p-value >0.01) were removed, reducing the number of probes analysed from 48,802 to 26,085.;GPL6884;Graham,J.,Mann;graham.mann@sydney.edu.au;Melanoma Institute Australia;Poche Centre, 40 Rocklands Road;North Sydney;NSW;2060;Australia;NONE;26085;Reanalysis of: GSM1282590;1;83;86;Dead Not Melanoma;Male;Stage II;62,5;26,7
0,21091714;0;0;0,101372453;0,027756949;0;0,659953458;GSM1315972;melanoma AJCCstageIII TumourID172;Public on Aug 18 2014;Jan 28 2014;Aug 18 2014;RNA;1;melanoma lymph node, fresh frozen tissue (>80% tumor cell content, <30% necrosis);Homo sapiens;patient age at primary diagnosis (years): 68;patient sex: Female;patient age at stage iii sample banked (years): 75;survival from stage iii tumour banked (months): 115.99;survival from primary melanoma (months): 200.65;patient last status: Alive NSR;number of primary melanomas: 2;stage at primary diagnosis 5th edition: Stage I;Tissue samples were homogenized using a high-speed agitation polytron blender (Kinematica, Luzern, Switzerland) in the presence of Trizol.;Total RNA was extracted from 20-30mg of fresh frozen tissue.;total RNA;The RNA was isolated and purified with an RNeasy purification kit (Qiagen RNeasy purification kit- Qiagen Pty Ltd., Clifton Hill, Victoria, Australia) with DNAse I digestion on the column. The quality of the RNA preparations was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA, USA). RNA integrity scores were >8 for all samples analyzed.;biotin;cRNA amplification and labelling with biotin were performed using Illumina TotalPrep RNA amplification kit according to the manufacturer’s directions (Ambion, Inc., Austin, TX, USA) with 250ng total RNA as input material.;9606;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Quality control was performed on all chips using R/Bioconductor and the lumi package (www.bioconductor.org). Data normalization was performed using a variance-stabilizing transform (VST) and quantile normalization as implemented in the lumi package for R/Bioconductor. To reduce false positives, unexpressed genes (detection p-value >0.01) were removed, reducing the number of probes analysed from 48,802 to 26,085.;GPL6884;Graham,J.,Mann;graham.mann@sydney.edu.au;Melanoma Institute Australia;Poche Centre, 40 Rocklands Road;North Sydney;NSW;2060;Australia;NONE;26085;Reanalysis of: GSM1282632;2;68;75;Alive NSR;Female;Stage I;200,65;115,99
0,134696894;0,026699058;0,071202165;0,041700038;0,013349346;0,05695746;0,65539504;GSM1315973;melanoma AJCCstageIII TumourID66;Public on Aug 18 2014;Jan 28 2014;Aug 18 2014;RNA;1;melanoma lymph node, fresh frozen tissue (>80% tumor cell content, <30% necrosis);Homo sapiens;patient age at primary diagnosis (years): 47;patient sex: Male;patient age at stage iii sample banked (years): 47;survival from stage iii tumour banked (months): 49.25;survival from primary melanoma (months): 50.20;patient last status: Alive NSR;number of primary melanomas: 1;stage at primary diagnosis 5th edition: Stage III;Tissue samples were homogenized using a high-speed agitation polytron blender (Kinematica, Luzern, Switzerland) in the presence of Trizol.;Total RNA was extracted from 20-30mg of fresh frozen tissue.;total RNA;The RNA was isolated and purified with an RNeasy purification kit (Qiagen RNeasy purification kit- Qiagen Pty Ltd., Clifton Hill, Victoria, Australia) with DNAse I digestion on the column. The quality of the RNA preparations was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA, USA). RNA integrity scores were >8 for all samples analyzed.;biotin;cRNA amplification and labelling with biotin were performed using Illumina TotalPrep RNA amplification kit according to the manufacturer’s directions (Ambion, Inc., Austin, TX, USA) with 250ng total RNA as input material.;9606;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Quality control was performed on all chips using R/Bioconductor and the lumi package (www.bioconductor.org). Data normalization was performed using a variance-stabilizing transform (VST) and quantile normalization as implemented in the lumi package for R/Bioconductor. To reduce false positives, unexpressed genes (detection p-value >0.01) were removed, reducing the number of probes analysed from 48,802 to 26,085.;GPL6884;Graham,J.,Mann;graham.mann@sydney.edu.au;Melanoma Institute Australia;Poche Centre, 40 Rocklands Road;North Sydney;NSW;2060;Australia;NONE;26085;Reanalysis of: GSM1282614;1;47;47;Alive NSR;Male;Stage III;50,2;49,25
0,080895771;0,00925652;0,026897252;0,020339152;0,039875125;0,127226696;0,695509484;GSM1315974;melanoma AJCCstageIII TumourID16;Public on Aug 18 2014;Jan 28 2014;Aug 18 2014;RNA;1;melanoma lymph node, fresh frozen tissue (>80% tumor cell content, <30% necrosis);Homo sapiens;patient age at primary diagnosis (years): 48;patient sex: Female;patient age at stage iii sample banked (years): 48;survival from stage iii tumour banked (months): 70.72;survival from primary melanoma (months): 80.19;patient last status: Alive NSR;number of primary melanomas: 1;stage at primary diagnosis 5th edition: Stage I;Tissue samples were homogenized using a high-speed agitation polytron blender (Kinematica, Luzern, Switzerland) in the presence of Trizol.;Total RNA was extracted from 20-30mg of fresh frozen tissue.;total RNA;The RNA was isolated and purified with an RNeasy purification kit (Qiagen RNeasy purification kit- Qiagen Pty Ltd., Clifton Hill, Victoria, Australia) with DNAse I digestion on the column. The quality of the RNA preparations was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA, USA). RNA integrity scores were >8 for all samples analyzed.;biotin;cRNA amplification and labelling with biotin were performed using Illumina TotalPrep RNA amplification kit according to the manufacturer’s directions (Ambion, Inc., Austin, TX, USA) with 250ng total RNA as input material.;9606;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Quality control was performed on all chips using R/Bioconductor and the lumi package (www.bioconductor.org). Data normalization was performed using a variance-stabilizing transform (VST) and quantile normalization as implemented in the lumi package for R/Bioconductor. To reduce false positives, unexpressed genes (detection p-value >0.01) were removed, reducing the number of probes analysed from 48,802 to 26,085.;GPL6884;Graham,J.,Mann;graham.mann@sydney.edu.au;Melanoma Institute Australia;Poche Centre, 40 Rocklands Road;North Sydney;NSW;2060;Australia;NONE;26085;Reanalysis of: GSM1282594;1;48;48;Alive NSR;Female;Stage I;80,19;70,72
0,160766309;0,122501818;0,100958288;0;0;0;0,615773586;GSM1315975;melanoma AJCCstageIII TumourID234;Public on Aug 18 2014;Jan 28 2014;Aug 18 2014;RNA;1;melanoma lymph node, fresh frozen tissue (>80% tumor cell content, <30% necrosis);Homo sapiens;patient age at primary diagnosis (years): 52;patient sex: Male;patient age at stage iii sample banked (years): 53;survival from stage iii tumour banked (months): 2.20;survival from primary melanoma (months): 19.40;patient last status: Dead Melanoma;number of primary melanomas: 1;stage at primary diagnosis 5th edition: Stage III;Tissue samples were homogenized using a high-speed agitation polytron blender (Kinematica, Luzern, Switzerland) in the presence of Trizol.;Total RNA was extracted from 20-30mg of fresh frozen tissue.;total RNA;The RNA was isolated and purified with an RNeasy purification kit (Qiagen RNeasy purification kit- Qiagen Pty Ltd., Clifton Hill, Victoria, Australia) with DNAse I digestion on the column. The quality of the RNA preparations was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA, USA). RNA integrity scores were >8 for all samples analyzed.;biotin;cRNA amplification and labelling with biotin were performed using Illumina TotalPrep RNA amplification kit according to the manufacturer’s directions (Ambion, Inc., Austin, TX, USA) with 250ng total RNA as input material.;9606;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Quality control was performed on all chips using R/Bioconductor and the lumi package (www.bioconductor.org). Data normalization was performed using a variance-stabilizing transform (VST) and quantile normalization as implemented in the lumi package for R/Bioconductor. To reduce false positives, unexpressed genes (detection p-value >0.01) were removed, reducing the number of probes analysed from 48,802 to 26,085.;GPL6884;Graham,J.,Mann;graham.mann@sydney.edu.au;Melanoma Institute Australia;Poche Centre, 40 Rocklands Road;North Sydney;NSW;2060;Australia;NONE;26085;Reanalysis of: GSM1282644;1;52;53;Dead Melanoma;Male;Stage III;19,4;2,2
0,056772237;0;0;0,195403871;0,078364354;0;0,669459537;GSM1315976;melanoma AJCCstageIII TumourID366;Public on Aug 18 2014;Jan 28 2014;Aug 18 2014;RNA;1;melanoma lymph node, fresh frozen tissue (>80% tumor cell content, <30% necrosis);Homo sapiens;patient age at primary diagnosis (years): 60;patient sex: Female;patient age at stage iii sample banked (years): 67;survival from stage iii tumour banked (months): 90.87;survival from primary melanoma (months): 177.14;patient last status: Alive with Melanoma;number of primary melanomas: 1;stage at primary diagnosis 5th edition: Stage I;Tissue samples were homogenized using a high-speed agitation polytron blender (Kinematica, Luzern, Switzerland) in the presence of Trizol.;Total RNA was extracted from 20-30mg of fresh frozen tissue.;total RNA;The RNA was isolated and purified with an RNeasy purification kit (Qiagen RNeasy purification kit- Qiagen Pty Ltd., Clifton Hill, Victoria, Australia) with DNAse I digestion on the column. The quality of the RNA preparations was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA, USA). RNA integrity scores were >8 for all samples analyzed.;biotin;cRNA amplification and labelling with biotin were performed using Illumina TotalPrep RNA amplification kit according to the manufacturer’s directions (Ambion, Inc., Austin, TX, USA) with 250ng total RNA as input material.;9606;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Quality control was performed on all chips using R/Bioconductor and the lumi package (www.bioconductor.org). Data normalization was performed using a variance-stabilizing transform (VST) and quantile normalization as implemented in the lumi package for R/Bioconductor. To reduce false positives, unexpressed genes (detection p-value >0.01) were removed, reducing the number of probes analysed from 48,802 to 26,085.;GPL6884;Graham,J.,Mann;graham.mann@sydney.edu.au;Melanoma Institute Australia;Poche Centre, 40 Rocklands Road;North Sydney;NSW;2060;Australia;NONE;26085;Reanalysis of: GSM1282663;1;60;67;Alive with Melanoma;Female;Stage I;177,14;90,87
0,130772799;0,002910575;0;0,017788315;0,025790926;0,295497583;0,527239802;GSM1315977;melanoma AJCCstageIII TumourID6;Public on Aug 18 2014;Jan 28 2014;Aug 18 2014;RNA;1;melanoma lymph node, fresh frozen tissue (>80% tumor cell content, <30% necrosis);Homo sapiens;patient age at primary diagnosis (years): 45;patient sex: Female;patient age at stage iii sample banked (years): 50;survival from stage iii tumour banked (months): 62.63;survival from primary melanoma (months): 124.08;patient last status: Dead Melanoma;number of primary melanomas: 1;stage at primary diagnosis 5th edition: Stage II;Tissue samples were homogenized using a high-speed agitation polytron blender (Kinematica, Luzern, Switzerland) in the presence of Trizol.;Total RNA was extracted from 20-30mg of fresh frozen tissue.;total RNA;The RNA was isolated and purified with an RNeasy purification kit (Qiagen RNeasy purification kit- Qiagen Pty Ltd., Clifton Hill, Victoria, Australia) with DNAse I digestion on the column. The quality of the RNA preparations was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA, USA). RNA integrity scores were >8 for all samples analyzed.;biotin;cRNA amplification and labelling with biotin were performed using Illumina TotalPrep RNA amplification kit according to the manufacturer’s directions (Ambion, Inc., Austin, TX, USA) with 250ng total RNA as input material.;9606;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Quality control was performed on all chips using R/Bioconductor and the lumi package (www.bioconductor.org). Data normalization was performed using a variance-stabilizing transform (VST) and quantile normalization as implemented in the lumi package for R/Bioconductor. To reduce false positives, unexpressed genes (detection p-value >0.01) were removed, reducing the number of probes analysed from 48,802 to 26,085.;GPL6884;Graham,J.,Mann;graham.mann@sydney.edu.au;Melanoma Institute Australia;Poche Centre, 40 Rocklands Road;North Sydney;NSW;2060;Australia;NONE;26085;Reanalysis of: GSM1282591;1;45;50;Dead Melanoma;Female;Stage II;124,08;62,63
0,045814765;0;0,009592507;0;0;0,505596838;0,43899589;GSM1315978;melanoma AJCCstageIII TumourID232;Public on Aug 18 2014;Jan 28 2014;Aug 18 2014;RNA;1;melanoma lymph node, fresh frozen tissue (>80% tumor cell content, <30% necrosis);Homo sapiens;patient age at primary diagnosis (years): 68;patient sex: Female;patient age at stage iii sample banked (years): 73;survival from stage iii tumour banked (months): 54.64;survival from primary melanoma (months): 110.56;patient last status: Dead Melanoma;number of primary melanomas: 4;stage at primary diagnosis 5th edition: Stage I;Tissue samples were homogenized using a high-speed agitation polytron blender (Kinematica, Luzern, Switzerland) in the presence of Trizol.;Total RNA was extracted from 20-30mg of fresh frozen tissue.;total RNA;The RNA was isolated and purified with an RNeasy purification kit (Qiagen RNeasy purification kit- Qiagen Pty Ltd., Clifton Hill, Victoria, Australia) with DNAse I digestion on the column. The quality of the RNA preparations was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA, USA). RNA integrity scores were >8 for all samples analyzed.;biotin;cRNA amplification and labelling with biotin were performed using Illumina TotalPrep RNA amplification kit according to the manufacturer’s directions (Ambion, Inc., Austin, TX, USA) with 250ng total RNA as input material.;9606;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Quality control was performed on all chips using R/Bioconductor and the lumi package (www.bioconductor.org). Data normalization was performed using a variance-stabilizing transform (VST) and quantile normalization as implemented in the lumi package for R/Bioconductor. To reduce false positives, unexpressed genes (detection p-value >0.01) were removed, reducing the number of probes analysed from 48,802 to 26,085.;GPL6884;Graham,J.,Mann;graham.mann@sydney.edu.au;Melanoma Institute Australia;Poche Centre, 40 Rocklands Road;North Sydney;NSW;2060;Australia;NONE;26085;Reanalysis of: GSM1282642;4;68;73;Dead Melanoma;Female;Stage I;110,56;54,64
0,065476503;0,04063641;0,057763136;0;0;0,349785924;0,486338027;GSM1315979;melanoma AJCCstageIII TumourID43;Public on Aug 18 2014;Jan 28 2014;Aug 18 2014;RNA;1;melanoma lymph node, fresh frozen tissue (>80% tumor cell content, <30% necrosis);Homo sapiens;patient age at primary diagnosis (years): 78;patient sex: Male;patient age at stage iii sample banked (years): 80;survival from stage iii tumour banked (months): 24.46;survival from primary melanoma (months): 43.53;patient last status: Alive Status Unknown;number of primary melanomas: 2;stage at primary diagnosis 5th edition: Stage I;Tissue samples were homogenized using a high-speed agitation polytron blender (Kinematica, Luzern, Switzerland) in the presence of Trizol.;Total RNA was extracted from 20-30mg of fresh frozen tissue.;total RNA;The RNA was isolated and purified with an RNeasy purification kit (Qiagen RNeasy purification kit- Qiagen Pty Ltd., Clifton Hill, Victoria, Australia) with DNAse I digestion on the column. The quality of the RNA preparations was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA, USA). RNA integrity scores were >8 for all samples analyzed.;biotin;cRNA amplification and labelling with biotin were performed using Illumina TotalPrep RNA amplification kit according to the manufacturer’s directions (Ambion, Inc., Austin, TX, USA) with 250ng total RNA as input material.;9606;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Quality control was performed on all chips using R/Bioconductor and the lumi package (www.bioconductor.org). Data normalization was performed using a variance-stabilizing transform (VST) and quantile normalization as implemented in the lumi package for R/Bioconductor. To reduce false positives, unexpressed genes (detection p-value >0.01) were removed, reducing the number of probes analysed from 48,802 to 26,085.;GPL6884;Graham,J.,Mann;graham.mann@sydney.edu.au;Melanoma Institute Australia;Poche Centre, 40 Rocklands Road;North Sydney;NSW;2060;Australia;NONE;26085;Reanalysis of: GSM1282603;2;78;80;Alive Status Unknown;Male;Stage I;43,53;24,46
0,090585355;0,148774553;0,081918993;0;0;0,098277754;0,580443344;GSM1315980;melanoma AJCCstageIII TumourID242;Public on Aug 18 2014;Jan 28 2014;Aug 18 2014;RNA;1;melanoma lymph node, fresh frozen tissue (>80% tumor cell content, <30% necrosis);Homo sapiens;patient age at primary diagnosis (years): 56;patient sex: Female;patient age at stage iii sample banked (years): 56;survival from stage iii tumour banked (months): 14.96;survival from primary melanoma (months): 23.61;patient last status: Dead Melanoma;number of primary melanomas: 1;stage at primary diagnosis 5th edition: Stage II;Tissue samples were homogenized using a high-speed agitation polytron blender (Kinematica, Luzern, Switzerland) in the presence of Trizol.;Total RNA was extracted from 20-30mg of fresh frozen tissue.;total RNA;The RNA was isolated and purified with an RNeasy purification kit (Qiagen RNeasy purification kit- Qiagen Pty Ltd., Clifton Hill, Victoria, Australia) with DNAse I digestion on the column. The quality of the RNA preparations was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA, USA). RNA integrity scores were >8 for all samples analyzed.;biotin;cRNA amplification and labelling with biotin were performed using Illumina TotalPrep RNA amplification kit according to the manufacturer’s directions (Ambion, Inc., Austin, TX, USA) with 250ng total RNA as input material.;9606;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Quality control was performed on all chips using R/Bioconductor and the lumi package (www.bioconductor.org). Data normalization was performed using a variance-stabilizing transform (VST) and quantile normalization as implemented in the lumi package for R/Bioconductor. To reduce false positives, unexpressed genes (detection p-value >0.01) were removed, reducing the number of probes analysed from 48,802 to 26,085.;GPL6884;Graham,J.,Mann;graham.mann@sydney.edu.au;Melanoma Institute Australia;Poche Centre, 40 Rocklands Road;North Sydney;NSW;2060;Australia;NONE;26085;Reanalysis of: GSM1282646;1;56;56;Dead Melanoma;Female;Stage II;23,61;14,96
0,006284084;0,008113403;0,021817439;0;0;0,376723111;0,587061963;GSM1315981;melanoma AJCCstageIII TumourID1;Public on Aug 18 2014;Jan 28 2014;Aug 18 2014;RNA;1;melanoma lymph node, fresh frozen tissue (>80% tumor cell content, <30% necrosis);Homo sapiens;patient age at primary diagnosis (years): 74;patient sex: Female;patient age at stage iii sample banked (years): 74;survival from stage iii tumour banked (months): 1.74;survival from primary melanoma (months): 4.04;patient last status: Dead Melanoma;number of primary melanomas: 1;stage at primary diagnosis 5th edition: Stage II;Tissue samples were homogenized using a high-speed agitation polytron blender (Kinematica, Luzern, Switzerland) in the presence of Trizol.;Total RNA was extracted from 20-30mg of fresh frozen tissue.;total RNA;The RNA was isolated and purified with an RNeasy purification kit (Qiagen RNeasy purification kit- Qiagen Pty Ltd., Clifton Hill, Victoria, Australia) with DNAse I digestion on the column. The quality of the RNA preparations was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA, USA). RNA integrity scores were >8 for all samples analyzed.;biotin;cRNA amplification and labelling with biotin were performed using Illumina TotalPrep RNA amplification kit according to the manufacturer’s directions (Ambion, Inc., Austin, TX, USA) with 250ng total RNA as input material.;9606;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Quality control was performed on all chips using R/Bioconductor and the lumi package (www.bioconductor.org). Data normalization was performed using a variance-stabilizing transform (VST) and quantile normalization as implemented in the lumi package for R/Bioconductor. To reduce false positives, unexpressed genes (detection p-value >0.01) were removed, reducing the number of probes analysed from 48,802 to 26,085.;GPL6884;Graham,J.,Mann;graham.mann@sydney.edu.au;Melanoma Institute Australia;Poche Centre, 40 Rocklands Road;North Sydney;NSW;2060;Australia;NONE;26085;Reanalysis of: GSM1282589;1;74;74;Dead Melanoma;Female;Stage II;4,04;1,74
0,147725919;0;0;0,125501228;0,029511018;0;0,697261834;GSM1315982;melanoma AJCCstageIII TumourID194;Public on Aug 18 2014;Jan 28 2014;Aug 18 2014;RNA;1;melanoma lymph node, fresh frozen tissue (>80% tumor cell content, <30% necrosis);Homo sapiens;patient age at primary diagnosis (years): 66;patient sex: Male;patient age at stage iii sample banked (years): 75;survival from stage iii tumour banked (months): 14.56;survival from primary melanoma (months): 123.06;patient last status: Dead Melanoma;number of primary melanomas: 1;stage at primary diagnosis 5th edition: Stage I;Tissue samples were homogenized using a high-speed agitation polytron blender (Kinematica, Luzern, Switzerland) in the presence of Trizol.;Total RNA was extracted from 20-30mg of fresh frozen tissue.;total RNA;The RNA was isolated and purified with an RNeasy purification kit (Qiagen RNeasy purification kit- Qiagen Pty Ltd., Clifton Hill, Victoria, Australia) with DNAse I digestion on the column. The quality of the RNA preparations was assessed using the Agilent 2100 Bioanalyser (Agilent Technologies, Palo Alto, CA, USA). RNA integrity scores were >8 for all samples analyzed.;biotin;cRNA amplification and labelling with biotin were performed using Illumina TotalPrep RNA amplification kit according to the manufacturer’s directions (Ambion, Inc., Austin, TX, USA) with 250ng total RNA as input material.;9606;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Gene expression analysis was performed using the Sentrix Human-6 v3 Expression BeadChips (Illumina, Inc., San Diego, CA, USA), and BeadStation system from Illumina as per manufacturer’s instructions.;Quality control was performed on all chips using R/Bioconductor and the lumi package (www.bioconductor.org). Data normalization was performed using a variance-stabilizing transform (VST) and quantile normalization as implemented in the lumi package for R/Bioconductor. To reduce false positives, unexpressed genes (detection p-value >0.01) were removed, reducing the number of probes analysed from 48,802 to 26,085.;GPL6884;Graham,J.,Mann;graham.mann@sydney.edu.au;Melanoma Institute Australia;Poche Centre, 40 Rocklands Road;North Sydney;NSW;2060;Australia;NONE;26085;Reanalysis of: GSM1282635;1;66;75;Dead Melanoma;Male;Stage I;123,06;14,56